Halogenated alkyl alkoxy methyl ether compound, method for preparing 4, 6, 8, 10, 16-pentamethyldocosane from halogenated alkyl alkoxy methyl ether compound and method for preparing synthetic intermediate of halogenated alkyl alkoxy methyl ether compound
Halogenated alkyl alkoxymethyl ether compounds are used as intermediates to synthesize 4,6,8,10,16-pentamethyldocosane efficiently and economically, addressing the limitations of existing methods by reducing steps and environmental impact.
Patent Information
- Application Number
- CN202410691759.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-31
- Filing Date
- 2024-05-30
- Publication Date
- 2024-12-03
AI Technical Summary
Existing methods for synthesizing 4,6,8,10,16-pentamethyldocosane are not suitable for practical industrial production due to explosion hazards, fire hazards, use of toxic chemicals, and low yield, and they cannot efficiently synthesize various compounds with a 1,3-dimethyl skeleton.
The use of halogenated alkyl alkoxymethyl ether compounds as intermediates to synthesize 4,6,8,10,16-pentamethyldocosane through a series of nucleophilic addition, coupling, and halogenation reactions, reducing the number of steps and environmental impact.
This method provides an efficient and economical process for producing 4,6,8,10,16-pentamethyldocosane with fewer steps and reduced environmental impact, suitable for industrial applications.
Smart Images

Figure CN119059889A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a halogenated alkyl alkoxymethyl ether compound, and also relates to a method for preparing 4,6,8,10,16-pentamethyldocosane from the halogenated alkyl alkoxymethyl ether compound and a method for preparing a synthetic intermediate for preparing the halogenated alkyl alkoxymethyl ether compound. Background Art
[0002] Compounds having a 1,3-dimethyl skeleton are widely known, such as the cuticular hydrocarbon 4,6,8,10,16-pentamethyldocosane of Antitrogus parvulus, and the sex pheromone 2,4,6,8-tetramethylundecanol, 2,4,6,8,10-pentamethyltridecane, and 2,4,6,8,10,12,14,16-octamethylheptadecane of Margarodes prieskaensis. In particular, Antitrogus parvulus is a sugarcane pest in Australia that has been controlled by extensive use of organophosphorus insecticides, but has caused problems due to residual agricultural chemicals. Therefore, efforts have been made to minimize the use of insecticides in biological control methods, among which the use of cuticular hydrocarbons is expected to be high (Non-Patent Document 1 below).
[0003] Various compounds are known as cuticle hydrocarbons of Antitrogus parvulus, such as 4,6,8,10,16-pentamethyldocosane and 4,6,8,10,16,18-hexamethyldocosane (Non-Patent Document 1 below).
[0004] Methods for synthesizing 4,6,8,10,16-pentamethyldocosane include, for example, a method reported to have a yield of 3.28% for a total of 19 steps (Non-Patent Document 1 below). For example, 2,4,6-trimethylphenol is subjected to a hydrogenation reaction to obtain 2,4,6-trimethylcyclohexanol. The 2,4,6-trimethylcyclohexanol thus obtained is subjected to a Jones oxidation reaction, followed by a Baeyer-Villiger oxidation reaction with 3-chloroperoxybenzoic acid (mCPBA), and then a ring-opening reaction with sodium methoxide to obtain 6-hydroxy-2,4-dimethylheptanoic acid methyl ester. The hydroxyl group of the thus obtained 6-hydroxy-2,4-dimethylheptanoic acid methyl ester is protected with a tetrahydropyranyl group by using 3,4-dihydro-2H-pyran, and then the ester of 6-hydroxy-2,4-dimethylheptanoic acid methyl ester is subjected to a reduction reaction with lithium aluminum hydride to obtain 2,4-dimethyl-6-[(tetrahydro-2H-pyran-2-yl)oxy]-1-heptanol. The thus obtained 2,4-dimethyl-6-[(tetrahydro-2H-pyran-2-yl)oxy]-1-heptanol is subjected to an oxidation reaction with pyridinium chlorochromate (PCC) in a dichloromethane solvent, and then subjected to a Wittig reaction with ethyl 2-(triphenylphosphine)propionate. The carbon-carbon double bond is then subjected to a hydrogenation reaction with palladium-carbon, the ester is reduced with lithium aluminum hydride, and then the hydroxyl group is iodinated with triphenylphosphine, iodine and imidazole. The reaction mixture is then subjected to a coupling reaction with ethylmagnesium bromide, and then the tetrahydropyranyl group is removed with methanol under acidic conditions to obtain 4,6,8-trimethyl-2-undecanol. The hydroxyl group of 4,6,8-trimethyl-2-undecanol is then formylated with triethylamine and methanesulfonyl chloride, and then reacted with sodium cyanide in dimethyl sulfoxide (DMSO) to obtain 2,4,6,8-tetramethylundecane decane nitrile. 2,4,6,8-tetramethylundecane decane nitrile is then reacted with acetyl chloride in methanol, and then the nitrile group is converted into a carboxylic acid. The reaction mixture is then subjected to a reduction reaction with lithium aluminum hydride to obtain 2,4,6,8-tetramethyl-1-undecanol. The hydroxyl group of 2,4,6,8-tetramethyl-1-undecanol is then subjected to a Swern oxidation with triethylamine and oxalyl chloride in DMSO to obtain 2,4,6,8-tetramethyl-1-undecanol. Then, 2,4,6,8-tetramethyl-1-undecane is subjected to a Wittig reaction with (5-methylundecanylidene)triphenylphosphane, and the carbon-carbon double bond is reduced in the presence of a palladium-carbon catalyst to obtain 4,6,8,10,16-pentamethyldocosane.
[0005] Prior art
[0006] [Non-patent literature]
[0007] [Non-patent document 1] William Kitching et al., J. Org. Chem., 2005, 70, 1808-1827.
[0008] Purpose of the Invention
[0009] As described above, various compounds, such as 4,6,8,10,16-pentamethyldocosane and 4,6,8,10,16,18-hexamethyldocosane, are known as epidermal hydrocarbons of Antitrogus parvulus. Although the present disclosure focuses on 4,6,8,10,16-pentamethyldocosane, the present invention is not limited thereto. The method for preparing 4,6,8,10,16-pentamethyldocosane according to non-patent document 1 is not suitable for practical industrial preparation due to the explosion hazard in multiple steps using Jones oxidation, Baeyer-Villiger oxidation, PCC oxidation and Swern oxidation reactions, the fire hazard in multiple stages using lithium aluminum hydride and carbon palladium, and the use of highly toxic sodium cyanide. The large number of steps and low yield are also not suitable for practical industrial preparation. Furthermore, the production method of Non-Patent Document 1 can produce the cuticular hydrocarbons 4,6,8,10,16-pentamethyldocosane and 4,6,8,10,16,18-hexamethyldocosane of Antitrogus parvulus, but cannot widely synthesize various other compounds having a 1,3-dimethyl skeleton.
[0010] The present invention is made in view of the above situation, and its purpose is to provide a wide range of methods for preparing compounds with a 1,3-dimethyl skeleton. The present invention also aims to provide a new synthetic intermediate and a method for preparing the synthetic intermediate, which can be used to prepare compounds with a 1,3-dimethyl skeleton, especially 4,6,8,10,16-pentamethyldocosane. The present invention also aims to provide an efficient method for preparing 4,6,8,10,16-pentamethyldocosane from the above synthetic intermediate, and preferably to provide an efficient and economical preparation method. Summary of the invention
[0011] As a result of intensive research to overcome the above problems of the prior art, the present inventors have found that halogenated alkyl alkoxymethyl ether compounds are key intermediates that can be widely used to synthesize various compounds having a 1,3-dimethyl skeleton. The present inventors have further found a cheap and efficient method for preparing halogenated alkyl alkoxymethyl ether compounds, and a method for preparing the epidermal hydrocarbon compound 4,6,8,10,16-pentamethyldocosane of Antitrogus parvulus from halogenated alkyl alkoxymethyl ether compounds in fewer steps, thereby completing the present invention. The above preparation method is also found to be suitable for practical preparation in industry.
[0012] According to a first aspect of the present invention, there is provided a method for preparing a halogenated alkyl alkoxymethyl ether compound of the following general formula (1'):
[0013]
[0014] Where X 1 Represents a halogen atom, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group, and n represents an integer of 2 to 7,
[0015] The method comprises the following steps:
[0016] The following haloalkyl alkoxymethyl ether compound of general formula (1):
[0017]
[0018] Where X 1 , R 1 and n is defined as above,
[0019] Converted into a nucleophile (2n+2)-alkoxymethoxyalkyl compound of the following general formula (2):
[0020]
[0021] Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 Represents a halogen atom or Z 2 , and Z 2 express:
[0022]
[0023] Where R 1 and n are as defined above, and the wavy line indicates an abbreviated epitaxial structure;
[0024] The nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) is then subjected to a nucleophilic addition reaction with propylene oxide of the following formula (3):
[0025]
[0026] To obtain the following hydroxyalkyl alkoxymethyl ether compound of general formula (4):
[0027]
[0028] Where R 1 and n is as defined above;
[0029] And subjecting the hydroxyalkylalkoxymethyl ether compound (4) to a halogenation reaction to obtain the above-mentioned halogenated alkylalkoxymethyl ether compound (1').
[0030] According to a second aspect of the present invention, there is provided a method for preparing a haloalkylalkoxymethyl ether compound (1':n+1=3) according to the first aspect, wherein n represents 2 in the haloalkylalkoxymethyl ether compounds (1) and (1').
[0031] According to a third aspect of the present invention, there is provided a method for preparing 4,6,8,10,16-pentamethyldocosane of the following general formula (11):
[0032]
[0033] The method comprises the following steps:
[0034] A method for preparing a halogenated alkyl alkoxymethyl ether compound (1': n+1 = 3), for example, the method for preparing a halogenated alkyl alkoxymethyl ether compound (1': n+1 = 3) according to the first aspect, or another preparation method, for example, a method for preparing a halogenated alkyl alkoxymethyl ether compound (1': n+1 = 3) according to any one of Examples 5 and 6 of the present specification;
[0035] The halogenated alkyl alkoxymethyl ether compound (1': n+1 = 3) is converted into a nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound of the following general formula (2: n = 3):
[0036]
[0037] Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or an 8-alkoxymethoxy-1,3,5-trimethyloctyl group, and R 1 As defined above;
[0038] Then, a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) is subjected to a coupling reaction with a 1-halogeno-2-methylpentane compound of the following general formula (5):
[0039]
[0040] Where X 2 represents a halogen atom,
[0041] To obtain the following 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound of general formula (6):
[0042]
[0043] Where R1 As defined above;
[0044] The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) is subjected to a dealkoxymethylation reaction to obtain 4,6,8,10-tetramethyltridecyl alcohol of the following general formula (7):
[0045]
[0046] The 4,6,8,10-tetramethyltridecanol (7) is subjected to a halogenation reaction to obtain a 1-halogenated-4,6,8,10-tetramethyltridecanol compound of the following general formula (8):
[0047]
[0048] Where X 3 represents a halogen atom;
[0049] The 1-halogenated-4,6,8,10-tetramethyltridecane compound (8) is converted into a nucleophilic reagent 4,6,8,10-tetramethyltridecane compound of the following general formula (9):
[0050]
[0051] Among them, M 2 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or a 4,6,8,10-tetramethyltridecyl group;
[0052] And then the nucleophile 4,6,8,10-tetramethyltridecyl compound (9) is coupled with the 1-halogeno-3-methylnonane compound of the following general formula (10):
[0053]
[0054] Where X 4 represents a halogen atom,
[0055] To obtain the above-mentioned 4,6,8,10,16-pentamethyldocosane (11).
[0056] According to a fourth aspect of the present invention, there is provided a method for preparing 4,6,8,10,16-pentamethyldocosane of the following general formula (11):
[0057]
[0058] The method comprises the following steps:
[0059] The following halogenated alkyl alkoxymethyl ether compound of the general formula (1: n = 3):
[0060]
[0061] Where X 1 represents a halogen atom, and R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group,
[0062] Converted into a nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound of the following general formula (2: n = 3):
[0063]
[0064] Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or an 8-alkoxymethoxy-1,3,5-trimethyloctyl group, and R 1 As defined above;
[0065] Then, a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) is subjected to a coupling reaction with a 1-halogeno-2-methylpentane compound of the following general formula (5):
[0066]
[0067] Where X 2 represents a halogen atom,
[0068] To obtain the following 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound of general formula (6):
[0069]
[0070] Where R 1 As defined above;
[0071] The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) is subjected to a dealkoxymethylation reaction to obtain 4,6,8,10-tetramethyltridecyl alcohol of the following general formula (7):
[0072]
[0073] The 4,6,8,10-tetramethyltridecanol (7) is subjected to a halogenation reaction to obtain a 1-halogenated-4,6,8,10-tetramethyltridecanol compound of the following general formula (8):
[0074]
[0075] Where X 3 represents a halogen atom;
[0076] The above 1-halogenated-4,6,8,10-tetramethyltridecane compound (8) is converted into a nucleophilic reagent 4,6,8,10-tetramethyltridecane compound of the following general formula (9):
[0077]
[0078] Among them, M 2 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , and Z 1 represents a halogen atom or a 4,6,8,10-tetramethyltridecyl group;
[0079] And then the nucleophile 4,6,8,10-tetramethyltridecyl compound (9) is coupled with the 1-halogeno-3-methylnonane compound of the following general formula (10):
[0080]
[0081] Where X 4 represents a halogen atom,
[0082] To form the above-mentioned 4,6,8,10,16-pentamethyldocosane (11).
[0083] According to a fifth aspect of the present invention, there is provided a halogenated alkyl alkoxymethyl ether compound of the following general formula (1'):
[0084]
[0085] Where X 1 Represents a halogen atom, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group, and n represents an integer of 2 to 7.
[0086] According to the present invention, a halogenated alkyl alkoxymethyl ether compound can be prepared, which is a building block for widely synthesizing a compound having a 1,3-dimethyl skeleton. The halogenated alkyl alkoxymethyl ether compound can be used as a key intermediate to efficiently prepare a compound having a 1,3-dimethyl skeleton, 4,6,8,10,16-pentamethyldocosane, with less environmental impact and fewer steps. The preparation method is also economical. DETAILED DESCRIPTION
[0087] I. Halogenated alkyl alkoxymethyl ether compounds of the following general formulas (1) and (1')
[0088] First, the haloalkylalkoxymethyl ether compounds (1) and (1') will be described in detail below.
[0089]
[0090] In each of the above general formulae (1) and (1'), X 1 represents a halogen atom. Halogen atom X 1 Examples of include chlorine atoms, bromine atoms, and iodine atoms. Chlorine atoms and bromine atoms are preferred. By using the chlorine atoms and bromine atoms, preferred reactivity can be ensured. Chlorine atoms are particularly preferred. By using the chlorine atoms, particularly preferred reactivity can be ensured.
[0091] In each of the above general formulae (1) and (1'), R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms and preferably 1 to 4 carbon atoms, or a phenyl group.
[0092] Examples of the normal alkyl group include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl and nonyl groups.
[0093] n represents an integer of 1 to 7. Depending on the value of n from 1 to 7, compound (1) may be compound (1: n = 1), compound (1: n = 2), compound (1: n = 3), compound (1: n = 4), compound (1: n = 5), compound (1: n = 6) and compound (1: n = 7) (hereinafter, the case where n is 1 to 7 is collectively referred to as compound (1: n = 1 to 7)). Similarly, depending on the value of n from 1 to 7, compound (1') may be compound (1': n + 1 = 2), compound (1': n + 1 = 3), compound (1': n + 1 = 4), compound (1': n + 1 = 5), compound (1': n + 1 = 6), compound (1': n + 1 = 7) and compound (1': n + 1 = 8) (hereinafter, the case where n is 1 to 7 is collectively referred to as compound (1': n + 1 = 2 to 8)). The present specification focuses on the halogenated alkyl alkoxymethyl ether compounds, wherein n is an integer of 2 to 7, preferably 2 to 6, as the target compound of the present invention. Therefore, compounds (1) wherein n is 2 to 7 are collectively referred to as compounds (1: n = 2 to 7), and compounds (1') wherein n is 2 to 7 are collectively referred to as compounds (1': n + 1 = 3 to 8).
[0094] Specific examples of the halogenated alkylalkoxymethyl ether compounds (1) and (1') include the following compounds:
[0095] 4-halopentyl alkoxymethyl ether compounds (1: n = 1), such as 4-chloropentyl methoxymethyl ether, 4-bromopentyl methoxymethyl ether, 4-iodopentyl methoxymethyl ether, 4-chloropentyl ethoxymethyl ether, 4-bromopentyl ethoxymethyl ether, 4-iodopentyl ethoxymethyl ether, 4-chloropentyl propoxymethyl ether, 4-bromopentyl propoxymethyl ether, 4-iodopentyl propoxymethyl ether, 4-chloropentyl butoxymethyl ether, 4-bromopentyl butoxymethyl ether, 4-iodopentyl butoxymethyl ether, 4-chloropentyl pentoxymethyl ether, 4-bromopentyl pentoxymethyl ether, 4-iodopentyl pentoxymethyl ether, 4-chloropentyl hexyloxymethyl ether, 4-bromopentylhexyloxymethyl ether, 4-iodopentylhexyloxymethyl ether, 4-chloropentylheptyloxymethyl ether, 4-bromopentylheptyloxymethyl ether, 4-iodopentylheptyloxymethyl ether, 4-chloropentyloctyloxymethyl ether, 4-bromopentyloctyloxymethyl ether, 4-iodopentyloctyloxymethyl ether, 4-chloropentylnonyloxymethyl ether, 4-bromopentylnonyloxymethyl ether, 4-iodopentylnonyloxymethyl ether, 4-chloropentyldecyloxymethyl ether, 4-bromopentyldecyloxymethyl ether, 4-iodopentyldecyloxymethyl ether, 4-chloropentylbenzyloxymethyl ether, 4-bromopentylbenzyloxymethyl ether, and 4-iodopentylbenzyloxymethyl ether;
[0096] 6-halogenated-4-methylheptyl alkoxymethyl ether compounds ((1:n=2) or (1':n+1=2)), such as 6-chloro-4-methylheptyl methoxymethyl ether, 6-bromo-4-methylheptyl methoxymethyl ether, 6-iodo-4-methylheptyl methoxymethyl ether, 6-chloro-4-methylheptyl ethoxymethyl ether, 6-bromo-4-methylheptyl ethoxymethyl ether, 6-iodo-4-methylheptyl ethoxymethyl ether, 6-chloro-4-methylheptyl ethoxymethyl ether, -methylheptyl propoxymethyl ether, 6-bromo-4-methylheptyl propoxymethyl ether, 6-iodo-4-methylheptyl propoxymethyl ether, 6-chloro-4-methylheptyl butoxymethyl ether, 6-bromo-4-methylheptyl butoxymethyl ether, 6-iodo-4-methylheptyl butoxymethyl ether, 6-chloro-4-methylheptyl pentoxymethyl ether, 6-bromo-4-methylheptyl pentoxymethyl ether, 6-iodo-4-methylheptyl pentoxymethyl ether, 6-chloro- 4-Methylheptylhexyloxymethyl ether, 6-bromo-4-methylheptylhexyloxymethyl ether, 6-iodo-4-methylheptylhexyloxymethyl ether, 6-chloro-4-methylheptylheptyloxymethyl ether, 6-bromo-4-methylheptylheptyloxymethyl ether, 6-iodo-4-methylheptylheptyloxymethyl ether, 6-chloro-4-methylheptyloctyloxymethyl ether, 6-bromo-4-methylheptyloctyloxymethyl ether, 6-iodo-4-methylheptyloctyloxymethyl ether, 6- Chloro-4-methylheptylnonoxymethyl ether, 6-bromo-4-methylheptylnonoxymethyl ether, 6-iodo-4-methylheptylnonoxymethyl ether, 6-chloro-4-methylheptyldecyloxymethyl ether, 6-bromo-4-methylheptyldecyloxymethyl ether, 6-iodo-4-methylheptyldecyloxymethyl ether, 6-chloro-4-methylheptylbenzyloxymethyl ether, 6-bromo-4-methylheptylbenzyloxymethyl ether, and 6-iodo-4-methylheptylbenzyloxymethyl ether;
[0097] 8-halogenated-4,6-dimethylnonyl alkoxymethyl ether compounds ((1:n=3) or (1':n+1=3)), such as 8-chloro-4,6-dimethylnonyl methoxymethyl ether, 8-bromo-4,6-dimethylnonyl methoxymethyl ether, 8-iodo-4,6-dimethylnonyl methoxymethyl ether, 8-chloro-4,6-dimethylnonyl ethoxymethyl ether, 8-bromo-4,6-dimethylnonyl ethoxymethyl ether, 8-iodo-4,6-dimethylnonyl ethoxymethyl ether, 8-chloro-4,6-dimethylnonyl 8-bromo-4,6-dimethylnonylpropoxymethylether, 8-iodo-4,6-dimethylnonylpropoxymethylether, 8-chloro-4,6-dimethylnonylbutoxymethylether, 8-bromo-4,6-dimethylnonylbutoxymethylether, 8-iodo-4,6-dimethylnonylbutoxymethylether, 8-chloro-4,6-dimethylnonylpentoxymethylether, 8-bromo-4,6-dimethylnonylpentoxymethylether, 8-iodo-4,6-dimethylnonylpentoxymethylether, 8-chloro-4,6-dimethylnonylpentoxymethylether -dimethylnonylhexyloxymethyl ether, 8-bromo-4,6-dimethylnonylhexyloxymethyl ether, 8-iodo-4,6-dimethylnonylhexyloxymethyl ether, 8-chloro-4,6-dimethylnonylheptyloxymethyl ether, 8-bromo-4,6-dimethylnonylheptyloxymethyl ether, 8-iodo-4,6-dimethylnonylheptyloxymethyl ether, 8-chloro-4,6-dimethylnonyloctyloxymethyl ether, 8-bromo-4,6-dimethylnonyloctyloxymethyl ether, 8-iodo-4,6-dimethylnonyloctyloxymethyl ether, 8-chloro- 4,6-dimethylnonylnonyloxymethyl ether, 8-bromo-4,6-dimethylnonylnonyloxymethyl ether, 8-iodo-4,6-dimethylnonylnonyloxymethyl ether, 8-chloro-4,6-dimethylnonyldecyloxymethyl ether, 8-bromo-4,6-dimethylnonyldecyloxymethyl ether, 8-iodo-4,6-dimethylnonyldecyloxymethyl ether, 8-chloro-4,6-dimethylnonylbenzyloxymethyl ether, 8-bromo-4,6-dimethylnonylbenzyloxymethyl ether, and 8-iodo-4,6-dimethylnonylbenzyloxymethyl ether;
[0098] 10-halogenated-4,6,8-trimethylundecylalkoxymethyl ether compounds ((1:n=4) or (1':n+1=4)), such as 10-chloro-4,6,8-trimethylundecylmethoxymethyl ether, 10-bromo-4,6,8-trimethylundecylmethoxymethyl ether, 10-iodo-4,6,8-trimethylundecylmethoxymethyl ether, 10-chloro-4,6,8-trimethylundecylethoxymethyl ether, 10-bromo-4,6,8-trimethylundecylethoxymethyl ether, 10-iodo-4,6,8-trimethylundecylethoxymethyl ether, 10-chloro-4,6,8-trimethylundecyl 10-bromo-4,6,8-trimethylundecylpropoxymethyl ether, 10-iodo-4,6,8-trimethylundecylpropoxymethyl ether, 10-chloro-4,6,8-trimethylundecylbutoxymethyl ether, 10-bromo-4,6,8-trimethylundecylbutoxymethyl ether, 10-iodo-4,6,8-trimethylundecylbutoxymethyl ether, 10-chloro-4,6,8-trimethylundecylpentyloxymethyl ether, 10-bromo-4,6,8-trimethylundecylpentyloxymethyl ether, 10-iodo-4,6,8-trimethylundecylpentyloxymethyl ether, 10-chloro-4,6,8-trimethylundecylpentyloxymethyl ether Methyl undecyl hexyloxymethyl ether, 10-bromo-4,6,8-trimethyl undecyl hexyloxymethyl ether, 10-iodo-4,6,8-trimethyl undecyl hexyloxymethyl ether, 10-chloro-4,6,8-trimethyl undecyl heptyloxymethyl ether, 10-bromo-4,6,8-trimethyl undecyl heptyloxymethyl ether, 10-iodo-4,6,8-trimethyl undecyl heptyloxymethyl ether, 10-chloro-4,6,8-trimethyl undecyl octyloxymethyl ether, 10-bromo-4,6,8-trimethyl undecyl octyloxymethyl ether, 10-iodo-4,6,8-trimethyl undecyl octyloxymethyl ether, 10-chloro-4 ,6,8-trimethylundecylnonyloxymethyl ether, 10-bromo-4,6,8-trimethylundecylnonyloxymethyl ether, 10-iodo-4,6,8-trimethylundecylnonyloxymethyl ether, 10-chloro-4,6,8-trimethylundecyldecyloxymethyl ether, 10-bromo-4,6,8-trimethylundecyldecyloxymethyl ether, 10-iodo-4,6,8-trimethylundecyldecyloxymethyl ether, 10-chloro-4,6,8-trimethylundecylbenzyloxymethyl ether, 10-bromo-4,6,8-trimethylundecylbenzyloxymethyl ether, and 10-iodo-4,6,8-trimethylundecylbenzyloxymethyl ether;
[0099] 12-halogenated-4,6,8,10-tetramethyltridecyl alkoxymethyl ether compounds ((1:n=5) or (1':n+1=5)), such as 12-chloro-4,6,8,10-tetramethyltridecyl methoxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecyl methoxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecyl methoxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecyl ethoxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecyl ethoxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecyl ethoxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecyl ethoxymethyl ether 12-bromo-4,6,8,10-tetramethyltridecylpropoxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecylpropoxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecylbutoxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecylbutoxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecylbutoxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecylpentoxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecylpentoxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecylpentoxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecylpentoxymethyl ether Methyl tridecyl hexyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyl tridecyl hexyloxymethyl ether, 12-iodo-4,6,8,10-tetramethyl tridecyl hexyloxymethyl ether, 12-chloro-4,6,8,10-tetramethyl tridecyl heptyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyl tridecyl heptyloxymethyl ether, 12-iodo-4,6,8,10-tetramethyl tridecyl heptyloxymethyl ether, 12-chloro-4,6,8,10-tetramethyl tridecyl octyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyl tridecyl octyloxymethyl ether, 12-iodo-4,6,8,10-tetramethyl tridecyl octyloxymethyl ether, 12-chloro-4,6 ,8,10-tetramethyltridecylnonyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecylnonyloxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecylnonyloxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, 12-iodo-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, 12-chloro-4,6,8,10-tetramethyltridecylbenzyloxymethyl ether, 12-bromo-4,6,8,10-tetramethyltridecylbenzyloxymethyl ether, and 12-iodo-4,6,8,10-tetramethyltridecylbenzyloxymethyl ether;
[0100] 14-halogenated-4,6,8,10,12-pentamethylpentadecyl alkoxymethyl ether compounds ((1:n=6) or (1':n+1=6)), such as 14-chloro-4,6,8,10,12-pentamethylpentadecyl methoxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecyl methoxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyl methoxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyl ethoxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecyl ethoxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyl ethoxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyl ethoxymethyl ether 12-Pentamethylpentadecyl propoxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecyl propoxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyl propoxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyl butoxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecyl butoxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyl butoxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyl pentoxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecyl pentoxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyl Pentyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecylhexyloxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecylhexyloxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecylhexyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether -4,6,8,10,12-pentamethylpentadecyloctyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecylnonyloxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecylnonyloxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecylnonyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether, 14-bromo-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether, 14-iodo-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether, 14-chloro-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether,12-pentamethylpentadecylbenzyloxymethyl ether, and 14-iodo-4,6,8,10,12-pentamethylpentadecylbenzyloxymethyl ether;
[0101] 17-halogenated-4,6,8,10,12,14-hexamethylheptadecyl alkoxymethyl ether compounds ((1:n=7) or (1':n+1=7)), such as 17-chloro-4,6,8,10,12,14-hexamethylheptadecyl methoxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecyl methoxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecyl methoxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecyl ethoxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecyl ethoxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecyl 17-chloro-4,6,8,10,12,14-hexamethylheptadecyl propoxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecyl propoxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecyl propoxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecyl butoxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecyl butoxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecyl butoxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecyl pentoxymethyl ether, 17-bromo-4,6,8,1 0,12,14-Hexamethylheptadecylpentyloxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecylpentyloxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecylhexyloxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecylhexyloxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecylhexyloxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecylheptyloxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecylheptyloxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecylheptyloxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecyloctyloxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecyloctyloxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecyloctyloxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecylnonyloxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecylnonyloxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecylnonyloxymethyl ether,14-hexamethylheptadecyldecyloxymethyl ether, 17-iodo-4,6,8,10,12,14-hexamethylheptadecyldecyloxymethyl ether, 17-chloro-4,6,8,10,12,14-hexamethylheptadecylbenzyloxymethyl ether, 17-bromo-4,6,8,10,12,14-hexamethylheptadecylbenzyloxymethyl ether, and 17-iodo-4,6,8,10,12,14-hexamethylheptadecylbenzyloxymethyl ether; and,
[0102] 19-halogenated-4,6,8,10,12,14,16-heptamethylnonadecyl alkoxymethyl ether compounds (1': n+1=8), such as 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecyl methoxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecyl methoxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecyl methoxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecyl ethoxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecyl ethoxymethyl ether, 19-iodo-4,6,8,10,12,14 ,16-heptamethylnonadecylethoxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylpropoxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecylpropoxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecylpropoxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylbutoxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecylbutoxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecylbutoxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylbutoxymethyl ether 14,16-heptamethylnonadecylpentyloxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecylpentyloxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecylpentyloxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylhexyloxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecylhexyloxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecylhexyloxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylhexyloxymethyl ether, 2,14,16-heptamethylnonadecylheptyloxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecylheptyloxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecyloctyloxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecyloctyloxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecyloctyloxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylnonyloxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecylnonyloxymethyl ether,12,14,16-heptamethylnonadecylnonyloxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecyldecyloxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecyldecyloxymethyl ether, 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecyldecyloxymethyl ether, 19-chloro-4,6,8,10,12,14,16-heptamethylnonadecylbenzyloxymethyl ether, 19-bromo-4,6,8,10,12,14,16-heptamethylnonadecylbenzyloxymethyl ether, and 19-iodo-4,6,8,10,12,14,16-heptamethylnonadecylbenzyloxymethyl ether.
[0103] Although the method for preparing the haloalkylalkoxymethyl ether compounds (1) and (1') is not particularly limited, for example, the methods according to Section II, Section III and Examples 2, 4, 5, 6 and 11 below can be used.
[0104] II. Method for preparing halogenated alkyl alkoxymethyl ether compound (1': n+1 = 2 to 8)
[0105] According to the preparation method of the following chemical reaction formula, a halogenated alkyl alkoxymethyl ether compound of the following general formula (1': n+1 = 2 to 8) is prepared from a halogenated alkyl alkoxymethyl ether compound (1: n = 1 to 7):
[0106]
[0107] Specifically, to prepare a halogenated alkyl alkoxymethyl ether compound (1': n+1 = 2 to 8), a halogenated alkyl alkoxymethyl ether compound (1: n = 1 to 7) is converted into a nucleophile (2n+2)-alkoxymethoxyalkyl compound (2). The nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) is then subjected to a nucleophilic addition reaction with propylene oxide (3) to prepare a hydroxyalkyl alkoxymethyl ether compound (4). The hydroxyalkyl alkoxymethyl ether compound (4) is then subjected to a halogenation reaction to form a halogenated alkyl alkoxymethyl ether compound (1': n+1 = 2 to 8).
[0108] (i) Nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2) and method for preparing nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2)
[0109] (a) The above-mentioned nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) will be described in detail below.
[0110] The nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) is represented by the following general formula (2):
[0111]
[0112] In the above general formula (2), M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 Represents a halogen atom or Z 2 , Z 2 It is expressed as:
[0113]
[0114] Where R 1 and n are as defined for the above general formulae (1) and (1′), and the wavy line indicates an abbreviated epitaxial structure. n is as defined above, and represents an integer from 1 to 7. Halogen atom Z 1 Examples of include a chlorine atom, a bromine atom and an iodine atom.
[0115] Nucleophile (2n+2)-alkoxymethoxyalkyl compound (2:M 1 =MgZ 1 ) is a Grignard reagent.
[0116] Specific examples of the nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2) include (2n+2)-alkoxymethoxyalkyl lithium; (2n+2)-alkoxymethoxyalkyl magnesium halide reagent (when M 1 =MgZ 1 When M is 2n+2), such as (2n+2)-alkoxymethoxyalkylmagnesium chloride, (2n+2)-alkoxymethoxyalkylmagnesium bromide and (2n+2)-alkoxymethoxyalkylmagnesium iodide (i.e., Grignard reagent); bis[(2n+2)-alkoxymethoxyalkyl] cuprate (when M is 2n+2)-alkoxymethoxyalkylmagnesium chloride, (2n+2)-alkoxymethoxyalkylmagnesium bromide and (2n+2)-alkoxymethoxyalkylmagnesium iodide (i.e., Grignard reagent); 1 =CuZ 1 and Gilman reagent (when M 1 =CuLiZ 1 When (when) such as bis[(2n+2)-alkoxymethoxyalkyl] lithium cuprate (i.e., Gilman reagent). Grignard reagents such as (2n+2)-alkoxymethoxyalkyl magnesium halide reagents are preferred. By using the Grignard reagents such as (2n+2)-alkoxymethoxyalkyl magnesium halide reagents, preferred reactivity can be ensured.
[0117] The nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) can be used not only to prepare the haloalkylalkoxymethyl ether compound (1'), but also to prepare 4,6,8,10,16-pentamethyldocosane, as shown in Section IV below, when n is 3, for the nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n = 3).
[0118] (b) The method for preparing the above-mentioned nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) will be described in detail below.
[0119] The nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) can be prepared from the above-mentioned halogenated alkylalkoxymethyl ether compound (1).
[0120] The method for preparing the nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2) will be described in detail as an example, wherein M 1 MgZ 1 , namely (2n+2)-alkoxymethoxyalkyl magnesium halide reagent (2:M 1 =MgZ 1 ).
[0121] (2n+2)-Alkoxymethoxyalkylmagnesium halide reagent (2:M 1 =MgZ 1 ) can be prepared, for example, by reacting the above-mentioned halogenated alkyl alkoxymethyl ether compound (1) with magnesium in a solvent, as shown in the following chemical reaction formula:
[0122]
[0123] The amount of magnesium used is preferably 1.0 to 2.0 gram atoms per mol of the haloalkylalkoxymethyl ether compound (1). By using the preferred amount, preferred completion of the reaction can be ensured.
[0124] Examples of solvents include general solvents, such as ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; and hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene. Preferred hydrocarbon solvents are toluene and xylene; and ether solvents are tetrahydrofuran, 2-methyltetrahydrofuran, and 4-methyltetrahydropyran. By using the hydrocarbon solvents such as toluene and xylene; and ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran, the preferred reaction rate for forming the above-mentioned Grignard reagent can be ensured. More preferred are tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran. By using the tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran, the preferred reaction rate for forming the above-mentioned Grignard reagent can be ensured.
[0125] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0126] The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mol of the haloalkylalkoxymethyl ether compound (1). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0127] The reaction temperature varies depending on the solvent used, but is preferably 30 to 120° C. By using the preferred reaction temperature, preferred reactivity can be ensured.
[0128] The reaction time varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0129] (ii) Hydroxyalkyl alkoxymethyl ether compound (4) and method for preparing the hydroxyalkyl alkoxymethyl ether compound (4)
[0130] (a) The hydroxyalkyl alkoxymethyl ether compound (4) will be described in detail below.
[0131] The hydroxyalkyl alkoxymethyl ether compound (4) is represented by the following general formula (4):
[0132]
[0133] In the above general formula (4), R 1 and n are as defined in formulae (1) and (1').
[0134] Specific examples of the hydroxyalkyl alkoxymethyl ether compound (4) include the following compounds:
[0135] 6-hydroxy-4-methylheptyl alkoxymethyl ether compounds (n=1) such as 6-hydroxy-4-methylheptyl methoxymethyl ether, 6-hydroxy-4-methylheptyl ethoxymethyl ether, 6-hydroxy-4-methylheptyl propoxymethyl ether, 6-hydroxy-4-methylheptyl butoxymethyl ether, 6-hydroxy-4-methylheptyl pentyloxymethyl ether, 6-hydroxy-4-methylheptyl hexyloxymethyl ether, 6-hydroxy-4-methylheptyl heptyloxymethyl ether, 6-hydroxy-4-methylheptyl octyloxymethyl ether, 6-hydroxy-4-methylheptyl nonyloxymethyl ether, 6-hydroxy-4-methylheptyl decyloxymethyl ether, and 6-hydroxy-4-methylheptyl benzyloxymethyl ether;
[0136] 8-hydroxy-4,6-dimethylnonyl alkoxymethyl ether compounds (n=2) such as 8-hydroxy-4,6-dimethylnonyl methoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl ethoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl propoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl butoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl pentoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl hexoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl heptoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl octoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl nonoxymethyl ether, 8-hydroxy-4,6-dimethylnonyl decoxymethyl ether, and 8-hydroxy-4,6-dimethylnonyl benzyloxymethyl ether;
[0137] 10-hydroxy-4,6,8-trimethylundecylalkoxymethyl ether compounds (n=3) such as 10-hydroxy-4,6,8-trimethylundecylmethoxymethyl ether, 10-hydroxy-4,6,8-trimethylundecylethoxymethyl ether, 10-hydroxy-4,6,8-trimethylundecylpropoxymethyl ether, 10-hydroxy-4,6,8-trimethylundecylbutoxymethyl ether, 10-hydroxy-4,6,8-trimethylundecylpentoxymethyl ether methyl ether, 10-hydroxy-4,6,8-trimethylundecylhexyloxymethyl ether, 10-hydroxy-4,6,8-trimethylundecylheptyloxymethyl ether, 10-hydroxy-4,6,8-trimethylundecyloctyloxymethyl ether, 10-hydroxy-4,6,8-trimethylundecylnonyloxymethyl ether, 10-hydroxy-4,6,8-trimethylundecyldecyloxymethyl ether, and 10-hydroxy-4,6,8-trimethylundecylbenzyloxymethyl ether;
[0138] 12-Hydroxy-4,6,8,10-tetramethyltridecyl alkoxymethyl ether compounds (n=4) such as 12-hydroxy-4,6,8,10-tetramethyltridecyl methoxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecyl ethoxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecyl propoxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecyl butoxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecyl pentoxymethyl ether, methyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecylhexyloxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecylheptyloxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecyloctyloxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecylnonyloxymethyl ether, 12-hydroxy-4,6,8,10-tetramethyltridecyldecyloxymethyl ether, and 12-hydroxy-4,6,8,10-tetramethyltridecylbenzyloxymethyl ether;
[0139] 14-hydroxy-4,6,8,10,12-pentamethylpentadecyl alkoxymethyl ether compounds (n=5) such as 14-hydroxy-4,6,8,10,12-pentamethylpentadecyl methoxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecyl ethoxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecyl propoxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecyl butoxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecyl pentoxymethyl ether methyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecylhexyloxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecylheptyloxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecyloctyloxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecylnonyloxymethyl ether, 14-hydroxy-4,6,8,10,12-pentamethylpentadecyldecyloxymethyl ether, and 14-hydroxy-4,6,8,10,12-pentamethylpentadecylbenzyloxymethyl ether;
[0140] 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyl alkoxymethyl ether compounds (n=6) such as 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyl methoxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyl ethoxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyl propoxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyl butoxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyl pentoxymethyl ether 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecylhexyloxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecylheptyloxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyloctyloxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecylnonyloxymethyl ether, 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecyldecyloxymethyl ether, and 16-hydroxy-4,6,8,10,12,14-hexamethylheptadecylbenzyloxymethyl ether; and
[0141] 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyl alkoxymethyl ether compounds (n=7) such as 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyl methoxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyl ethoxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyl propoxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyl butoxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyl pentoxymethyl ether 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecylhexyloxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecylheptyloxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyloctyloxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecylnonyloxymethyl ether, 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecyldecyloxymethyl ether, and 18-hydroxy-4,6,8,10,12,14,16-heptamethylnonadecylbenzyloxymethyl ether.
[0142] (b) The process for preparing the hydroxyalkyl alkoxymethyl ether compound (4) from the above-mentioned nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2) will be described in detail below.
[0143] The hydroxyalkyl alkoxymethyl ether compound (4) can be prepared from the above-mentioned nucleophilic (2n+2)-alkoxymethoxyalkyl compound (2).
[0144]
[0145] The preparation method comprises at least the step of subjecting a nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2) to a nucleophilic addition reaction with propylene oxide of the above general formula (3) to obtain a hydroxyalkyl alkoxymethyl ether compound (4).
[0146] In the above nucleophilic addition reaction, if necessary, a nucleophilic agent (2n+2)-alkoxymethoxyalkyl compound (2) may be used alone or in combination. The nucleophilic agent (2n+2)-alkoxymethoxyalkyl compound (2) may be synthesized by itself as described above in (i).
[0147] Propylene oxide (3) may be commercially available propylene oxide, or may be synthesized by itself.
[0148] In the nucleophilic addition reaction, the amount of the nucleophilic agent (2n+2)-alkoxymethoxyalkyl compound (2) used is preferably 0.6 to 1.3 mol per mol of propylene oxide (3). By using the preferred amount, preferred economy can be ensured.
[0149] If desired, a solvent may be incorporated into the nucleophilic addition reaction.
[0150] Examples of the solvent include general solvents, such as ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; and polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform. Preferred hydrocarbon solvents are toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile. By using the hydrocarbon solvents such as toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile, preferred reactivity can be ensured. Tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene are more preferred. By using the tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene, more preferred reactivity can be ensured.
[0151] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0152] The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mol of the nucleophile (2n+2)-alkoxymethoxyalkyl compound (2). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0153] If necessary, the nucleophilic addition reaction can be carried out in the presence of a catalyst. Examples of catalysts include cuprous halides such as cuprous chloride, cuprous bromide and cuprous iodide; and cupric halides such as cupric chloride, cupric bromide and cupric iodide. Cuprous halides are preferred. By using the cuprous halides, preferred reactivity can be ensured. More preferred is cuprous chloride. By using the cuprous chloride, more preferred reactivity can be ensured.
[0154] If necessary, a catalyst may be used alone or in combination. The catalyst may be a commercially available catalyst.
[0155] The amount of the catalyst used is preferably 0.0001 to 0.300 mol, more preferably 0.0003 to 0.100 mol, per mol of the nucleophile (2n+2)-alkoxymethoxyalkyl compound (2). By using the preferred amount and the more preferred amount, a preferred reaction rate and / or post-treatment and a more preferred reaction rate and / or post-treatment can be ensured.
[0156] When the nucleophilic addition reaction is carried out in the presence of a catalyst, a cocatalyst may be used if necessary. Examples of cocatalysts include phosphorus compounds, such as trialkyl phosphites having 3 to 9 carbon atoms, such as triethyl phosphite; and triaryl phosphine compounds such as triphenylphosphine having 18 to 21 carbon atoms. Trialkyl phosphites having 3 to 9 carbon atoms which are preferably liquid at room temperature are used. By using the trialkyl phosphites having 3 to 9 carbon atoms, preferred treatment can be ensured.
[0157] If necessary, a co-catalyst may be used alone or in combination. The co-catalyst may be a commercially available co-catalyst.
[0158] When a co-catalyst is used, the amount of the co-catalyst used is preferably greater than 0 to 0.500 mol, more preferably greater than 0 to 0.200 mol, per mol of the nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0159] When the nucleophilic addition reaction is carried out in the presence of a catalyst, a lithium halide may be added, if necessary.
[0160] Examples of lithium halides include lithium chloride, lithium bromide, and lithium iodide. Lithium chloride is preferred. By using the lithium chloride, preferred reactivity can be ensured.
[0161] When lithium halide is used, the amount of lithium halide used is preferably greater than 0 to 0.250 mol per mol of the nucleophilic (2n+2)-alkoxymethoxyalkyl compound (2). By using the preferred amount, preferred reactivity can be ensured.
[0162] The reaction temperature of the nucleophilic addition reaction varies depending on the nucleophilic reagent (2n+2)-alkoxymethoxyalkyl compound (2) used, and is preferably -78 to 70° C., more preferably -20 to 50° C., and most preferably 5 to 35° C. By using the preferred reaction temperature, the more preferred reaction temperature, and the most preferred reaction temperature, preferred reactivity, more preferred reactivity, and most preferred reactivity can be ensured.
[0163] The reaction time of the nucleophilic addition reaction varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0164] (iii) Method for preparing a halogenated alkyl alkoxymethyl ether compound (1': n+1 = 2 to 8)
[0165] (a) The halogenated alkylalkoxymethyl ether compound (1': n+1 = 2 to 8) is as described above.
[0166] (b) The method for preparing the halogenated alkyl alkoxymethyl ether compound (1': n+1 = 2 to 8) will be described in detail below.
[0167] The halogenated alkyl alkoxymethyl ether compound (1': n+1 = 2 to 8) can be prepared from the above-mentioned hydroxyalkyl alkoxymethyl ether compound (4).
[0168]
[0169] The preparation method comprises the step of subjecting a hydroxyalkylalkoxymethyl ether compound (4) to a halogenation reaction.
[0170] The halogenation reaction can be carried out, for example, by tosylation of the hydroxyl group with a p-toluenesulfonyl halide compound and then halogenation with a metal salt lithium halide compound; or by directly halogenating the hydroxyl group with a halogenating agent.
[0171] Examples of the halogenating agent include halogens such as chlorine, bromine and iodine; hydrogen halide compounds such as hydrogen chloride, hydrogen bromide and hydrogen iodide; methanesulfonyl halide compounds such as methanesulfonyl chloride, methanesulfonyl bromide and methanesulfonyl iodide; benzenesulfonyl halide compounds such as benzenesulfonyl chloride, benzenesulfonyl bromide and benzenesulfonyl iodide; p-toluenesulfonyl halide compounds such as p-toluenesulfonyl chloride, p-toluenesulfonyl bromide and p-toluenesulfonyl iodide; thionyl halide compounds such as thionyl chloride, thionyl bromide and thionyl iodide; phosphorus halide compounds such as phosphorus trichloride, phosphorus pentachloride and phosphorus tribromide; carbon tetrahalide compounds such as carbon tetrachloride, carbon tetrabromide and carbon tetraiodide; alkylsilyl halide compounds such as Compounds such as trimethylsilyl chloride, trimethylsilyl bromide, trimethylsilyl iodide, triethylsilyl chloride, triethylsilyl bromide, triethylsilyl iodide, triisopropylsilyl chloride, triisopropylsilyl bromide, triisopropylsilyl iodide, tert-butyldimethylsilyl chloride, tert-butyldimethylsilyl bromide and tert-butyldimethylsilyl iodide; oxalyl halide compounds such as oxalyl chloride, oxalyl bromide and oxalyl iodide; and N-halogenated succinimide compounds such as N-chlorosuccinimide, N-bromosuccinimide and N-iodosuccinimide. Methanesulfonyl halide compounds, benzenesulfonyl halide compounds, p-toluenesulfonyl halide compounds and thionyl halide compounds are preferred. By using the methanesulfonyl halide compound, benzenesulfonyl halide compound, p-toluenesulfonyl halide compound and thionyl halide compound, preferred side reaction suppression can be ensured. Methanesulfonyl halide compound, benzenesulfonyl halide compound and thionyl halide compound are particularly preferred. By using the methanesulfonyl halide compound, benzenesulfonyl halide compound and thionyl halide compound, particularly preferred side reaction suppression can be ensured.
[0172] If necessary, a halogenating agent may be used alone or in combination. The halogenating agent may be a commercially available halogenating agent.
[0173] The amount of the halogenating agent used is preferably 0.8 to 5.0 mol, more preferably 1.0 to 2.5 mol, per mol of the hydroxyalkylalkoxymethyl ether compound (4). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0174] If necessary, a base may be incorporated in the halogenation reaction.
[0175] Examples of the base include hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide and magnesium hydroxide; carbonates such as sodium carbonate, potassium carbonate, calcium carbonate and magnesium carbonate; and amines such as triethylamine, N,N-diisopropylethylamine, piperidine, pyrrolidine, pyridine, lutidine, 4-dimethylaminopyridine, N,N-dimethylaniline, N,N-diethylaniline and 1,8-diazabicyclo[5.4.0]-7-undecene (DBU).
[0176] When a methanesulfonyl halide compound, a benzenesulfonyl halide compound, a p-toluenesulfonyl halide compound or the like is used as the above-mentioned halogenating agent, the base is preferably an amine, more preferably a pyridine such as pyridine, lutidine and 4-dimethylaminopyridine.
[0177] When a thionyl halide compound is used as the halogenating agent, the base is preferably an amine, more preferably a trialkylamine such as triethylamine.
[0178] If necessary, a base may be used alone or in combination. The base may be a commercially available base.
[0179] When a base is used, the amount of the base used is preferably greater than 0 to 8.0 mol, more preferably greater than 0 to 3.0 mol, per mol of the hydroxyalkylalkoxymethyl ether compound (4). By using the preferred amount and the more preferred amount, a preferred yield and / or economy and a more preferred yield and / or economy can be ensured.
[0180] If desired, a metal salt may be incorporated into the halogenation reaction.
[0181] Examples of the metal salt include lithium salts such as lithium chloride, lithium bromide and lithium iodide; sodium salts such as sodium chloride, sodium bromide and sodium iodide; potassium salts such as potassium chloride, potassium bromide and potassium iodide; calcium salts such as calcium chloride, calcium bromide and calcium iodide; and magnesium salts such as magnesium chloride, magnesium bromide and magnesium iodide.
[0182] When the halogenation is carried out using a metal salt lithium halide compound after the tosylation, the reaction is carried out using, for example, a lithium salt such as lithium chloride, lithium bromide and lithium iodide.
[0183] If necessary, metal salts may be used alone or in combination. The metal salt may be a commercially available metal salt.
[0184] When a metal salt is used, the amount of the metal salt used is preferably greater than 0 to 30.0 mol, more preferably greater than 0 to 5.0 mol, per mol of the hydroxyalkylalkoxymethyl ether compound (4). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0185] Although metal salts increase the concentration of halide ions in the reaction system, thereby improving reactivity, it is preferred not to incorporate metal salts into the reaction. By not incorporating metal salts, preferred economical properties and / or environmental protection can be ensured.
[0186] If necessary, a solvent may be incorporated in the halogenation reaction.
[0187] Examples of the solvent include general solvents, for example, ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, acetone, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform; and ester solvents such as methyl acetate, ethyl acetate, n-propyl acetate and n-butyl acetate. 2-methyltetrahydrofuran, 4-methyltetrahydropyran, dichloromethane, chloroform, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide and acetonitrile are preferred. By using the 2-methyltetrahydrofuran, 4-methyltetrahydropyran, dichloromethane, chloroform, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide and acetonitrile, preferred reactivity can be ensured. 2-methyltetrahydrofuran, γ-butyrolactone and acetonitrile are particularly preferred. By using the 2-methyltetrahydrofuran, γ-butyrolactone and acetonitrile, particularly preferred safety can be ensured.
[0188] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0189] When a solvent is incorporated in the halogenation reaction, the amount of the solvent used is preferably greater than 0 to 3000 g, more preferably greater than 0 to 800 g, per mol of the hydroxyalkylalkoxymethyl ether compound (4).
[0190] The solvent may occupy a portion of the reactor space, which reduces the space for the raw materials and reduces the productivity. Therefore, the reaction can be carried out without a solvent or using a base as a solvent.
[0191] The reaction temperature of the halogenation reaction varies depending on the halogenating agent used, and is preferably 5 to 180° C., more preferably 20 to 120° C. By using the preferred reaction temperature and the more preferred reaction temperature, preferred reactivity and more preferred reactivity can be ensured.
[0192] The reaction time of the halogenation reaction varies depending on the halogenating agent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0193] Therefore, the halogenated alkyl alkoxymethyl ether compound (1':n+1) can be prepared by homologation of three carbons of the halogenated alkyl alkoxymethyl ether compound (1:n). Then, by repeatedly using the halogenated alkyl alkoxymethyl ether compound (1') thus prepared as the halogenated alkyl alkoxymethyl ether compound (1:n), converting the halogenated alkyl alkoxymethyl ether compound (1:n) into a nucleophile, and then subjecting the nucleophile to a nucleophilic addition reaction with propylene oxide and a halogenation reaction, the n of the halogenated alkyl alkoxymethyl ether compound (1) can be increased without limit. Specifically, the methyl side chains can be increased without limit to widely prepare various compounds having a 1,3-dimethyl skeleton, such as 2,4,6,8-tetramethyl-1-undecanol, 2,4,6,8,10,12,14,16-octamethylheptadecanol, 4,6,8,10,16-pentamethyldocosane and 4,6,8,10,16,18-hexamethyldocosane, as shown in the following reaction formula:
[0194]
[0195] III. Method for preparing halogenated alkyl alkoxymethyl ether compound (1:n=1)
[0196] When n is 1 in the above general formula (1), the halogenated alkyl alkoxymethyl ether compound (1:n=1) (also known as a 4-halopentyl alkoxymethyl ether compound) can be prepared according to, for example, the preparation method of the following chemical reaction formula:
[0197]
[0198] Specifically, the above-mentioned 4-haloalkylalkoxymethyl ether compound (1:n=1), i.e., 4-halopentanylalkoxymethyl ether compound, can be prepared by opening the tetrahydrofuran ring of 2-methyltetrahydrofuran with an acyl halide, then eliminating the acyl group, and then alkoxymethylating the hydroxyl group.
[0199] (i) 4-halopentyl acylate compound (13) and method for preparing 4-halopentyl acylate compound (13)
[0200] (a) The 4-halopentyl acylate compound (13) will be described in detail below.
[0201] The 4-halopentyl acylate compound (13) is represented by the following general formula (13):
[0202]
[0203] In the above general formula (13), R 2 represents an alkyl group having 1 to 9 carbon atoms, or a phenyl group, and X 1 As defined in formulae (1) and (1').
[0204] Alkyl R 2 Examples of include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl and tert-butyl.
[0205] Halogen AtomX 1 Examples of include chlorine atoms, bromine atoms, and iodine atoms. Chlorine atoms and bromine atoms are preferred. By using the chlorine atoms and bromine atoms, preferred reactivity can be ensured. Chlorine atoms are particularly preferred. By using the chlorine atoms, particularly preferred reactivity can be ensured.
[0206] Specific examples of the 4-halopentyl acylate compound (13) include 4-chloropentyl acetate, 4-bromopentyl acetate, 4-iodopentyl acetate, 4-chloropentyl propionate, 4-bromopentyl propionate, 4-iodopentyl propionate, 4-chloropentyl butyrate, 4-bromopentyl butyrate, 4-iodopentyl butyrate, 4-chloropentyl valerate, 4-bromopentyl valerate, 4-iodopentyl valerate, 4-chloropentyl pivalate, 4-bromopentyl pivalate, 4-iodopentyl pivalate, 4-chloropentyl benzoate, 4-bromopentyl benzoate, and 4-iodopentyl benzoate.
[0207] (b) The process for preparing the above-mentioned 4-halopentyl acylate compound (13) will be described in detail below.
[0208] 4-Halopentyl acylate compound (13) can be prepared from 2-methyltetrahydrofuran and acyl halide (12) as shown in the following chemical reaction formula:
[0209]
[0210] The preparation method comprises the step of opening the tetrahydrofuran ring of 2-methyltetrahydrofuran with an acid halide (12).
[0211] The acid halide (12) will be described in detail below.
[0212] The acyl halide (12) is represented by the following general formula (12):
[0213]
[0214] In the general formula (12), R 2 and X 1 As defined in general formula (13).
[0215] Specific examples of the acyl halide (12) include acetyl halide compounds such as acetyl chloride, acetyl bromide and acetyl iodide; propionyl halide compounds such as propionyl chloride, propionyl bromide and propionyl iodide; butyryl halide compounds such as butyryl chloride, butyryl bromide and butyryl iodide; valeryl halide compounds such as valeryl chloride, valeryl bromide and valeryl iodide; pivaloyl halide compounds such as pivaloyl chloride, pivaloyl bromide and pivaloyl iodide; and benzoyl halide compounds such as benzoyl chloride, benzoyl bromide and benzoyl iodide.
[0216] The amount of the acid halide (12) used is preferably 0.7 to 1.5 mol, more preferably 0.8 to 1.1 mol, per mol of 2-methyltetrahydrofuran. By using the preferred amount and the more preferred amount, preferred reaction completion and more preferred reaction completion can be ensured.
[0217] If necessary, the ring-opening reaction can be carried out in the presence of a catalyst. Examples of catalysts include zinc halide compounds such as zinc chloride, zinc bromide and zinc iodide; titanium compounds such as titanium tetrachloride, titanium tetrabromide, titanium (IV) methoxide, titanium (IV) ethoxide, titanium (IV) isopropoxide, and titanium (IV) oxide; and zirconium compounds such as zirconium oxide. Zinc halide compounds are preferred. By using the zinc halide compounds, preferred reactivity can be ensured.
[0218] If necessary, a catalyst may be used alone or in combination. The catalyst may be a commercially available catalyst.
[0219] The amount of the catalyst used is preferably 0.0001 to 0.3 mol, more preferably 0.001 to 0.1 mol, per mol of 2-methyltetrahydrofuran. By using the preferred amount and the more preferred amount, preferred reaction completion and more preferred reaction completion can be ensured.
[0220] If desired, a solvent may be incorporated into the ring-opening reaction.
[0221] Examples of the solvent include those that do not affect the reaction, for example, hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene. From the viewpoint of ease of preparation, 2-methyltetrahydrofuran can be used as a solvent and a substrate without using other solvents.
[0222] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0223] When a solvent is used, the amount of the solvent used is preferably greater than 0 to 3000 g, more preferably greater than 0 to 500 g, per mol of 2-methyltetrahydrofuran. By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0224] The reaction temperature varies depending on the production scale, and is preferably -15 to 85° C., more preferably -10 to 45° C. By using the preferred reaction temperature and the more preferred reaction temperature, preferred reactivity and more preferred reactivity can be ensured.
[0225] The reaction time varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0226] (ii) 4-halogeno-1-pentanol compound (15) and method for preparing 4-halogeno-1-pentanol compound (15)
[0227] (a) The 4-halogeno-1-pentanol compound (15) will be described in detail below.
[0228] The 4-halogeno-1-pentanol compound (15) is represented by the following general formula (15):
[0229]
[0230] In the above general formula (15), X 1 As defined in general formula (12).
[0231] Specific examples of the 4-halogeno-1-pentanol compound (15) include 4-chloro-1-pentanol, 4-bromo-1-pentanol and 4-iodo-1-pentanol.
[0232] (b) The process for preparing the above-mentioned 4-halogeno-1-pentanol compound (15) will be described in detail below.
[0233] 4-Halo-1-pentanol compound (15) can be prepared by using an organometallic reagent R 3 M 3 (14) Prepared by deacylating the acyl group of the above-mentioned 4-halopentyl acylate compound (13).
[0234]
[0235] In the above general formula (14), R 3 represents an alkyl group having 1 to 14 carbon atoms, preferably 1 to 8 carbon atoms, or an ethynyl group.
[0236] Alkyl R 3 Examples of include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, and tetradecyl.
[0237] In the above general formula (14), M 3 Indicates Li, Na, K, Ag, MgZ 1 or CaZ1 , Z 1 Represents a halogen atom or R 3 . Halogen atom Z 1 Examples of include a chlorine atom, a bromine atom and an iodine atom.
[0238] Organometallic Reagents 3 M 3 Specific examples of (14) include Grignard reagents such as alkyl lithiums such as methyl lithium, ethyl lithium, propyl lithium, n-butyl lithium, sec-butyl lithium, tert-butyl lithium, pentyl lithium, hexyl lithium, heptyl lithium, octyl lithium, nonyl lithium and decyl lithium; methyl magnesium halide compounds such as methyl magnesium chloride, methyl magnesium bromide, and methyl magnesium iodide; ethyl magnesium halide compounds such as ethyl magnesium chloride, ethyl magnesium bromide, and ethyl magnesium iodide; propyl magnesium halide compounds such as propyl magnesium chloride, propyl magnesium bromide, and propyl magnesium iodide; butyl magnesium halide compounds such as butyl magnesium chloride, butyl magnesium bromide, and butyl magnesium iodide; pentyl magnesium halide compounds such as Amyl magnesium chloride, amyl magnesium bromide, and amyl magnesium iodide; hexyl magnesium halide compounds such as hexyl magnesium chloride, hexyl magnesium bromide, and hexyl magnesium iodide; heptyl magnesium halide compounds such as heptyl magnesium chloride, heptyl magnesium bromide, and heptyl magnesium iodide; octyl magnesium halide compounds such as octyl magnesium chloride, octyl magnesium bromide, and octyl magnesium iodide; nonyl magnesium halide compounds such as nonyl magnesium chloride, nonyl magnesium bromide, and nonyl magnesium iodide; decyl magnesium halide compounds such as decyl magnesium chloride, decyl magnesium bromide, and decyl magnesium iodide; and metal acetylides such as lithium acetylide, sodium acetylide, potassium acetylide, calcium acetylide, and silver acetylide. Grignard reagents are preferred. By using the Grignard reagents, preferred reactivity can be ensured.
[0239] The amount of the organometallic reagent R used per mol of the 4-halopentyl acylate compound (13) is 3 M 3 The amount of (14) is preferably 1.5 to 5.0 mol, more preferably 2.0 to 3.5 mol. By using the preferred amount and the more preferred amount, preferred reaction completion and more preferred reaction completion can be ensured.
[0240] If desired, a solvent may be incorporated during the deacylation.
[0241] Examples of the solvent include general solvents, such as ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; and polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform. Preferred hydrocarbon solvents are toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile. By using the hydrocarbon solvents such as toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile, preferred reactivity can be ensured. Tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene are more preferred. By using the tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene, more preferred reactivity can be ensured.
[0242] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0243] When a solvent is incorporated in the deacylation, the amount of the solvent used is preferably greater than 0 to 5000 g, more preferably greater than 0 to 3000 g, per mol of the 4-halopentyl acylate compound (13). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0244] The reaction temperature of the deacylation varies depending on the production scale, and is preferably -15 to 90° C., more preferably 10 to 50° C. By using the preferred reaction temperature and the more preferred reaction temperature, preferred reactivity and more preferred reactivity can be ensured.
[0245] The reaction time of the deacylation varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0246] (iii) 4-Halopentyl alkoxymethyl ether compound (1:n=1) and method for preparing the 4-Halopentyl alkoxymethyl ether compound (1:n=1)
[0247] (a) The 4-halopentylalkoxymethyl ether compound (1: n=1) is as described above.
[0248] (b) The method for preparing a 4-halopentylalkoxymethyl ether compound (1:n=1) will be described in detail below.
[0249] The 4-halopentyl alkoxymethyl ether compound (1: n=1) can be prepared from the above-mentioned 4-halo-1-pentanol compound (15).
[0250]
[0251] The preparation method comprises the step of alkoxymethylating a 4-halogeno-1-pentanol compound (15) with a halomethyl alkyl ether compound (16).
[0252] Hereinafter, the halomethyl alkyl ether compound (16) will be described in detail.
[0253] The halomethyl alkyl ether compound (16) is represented by the following general formula (16):
[0254]
[0255] In the above general formula (16), X 5 represents a halogen atom. Halogen atom X 5 Examples of include chlorine atoms, bromine atoms, and iodine atoms. Chlorine atoms and bromine atoms are preferred. By using the chlorine atoms and bromine atoms, preferred reactivity can be ensured. Chlorine atoms are particularly preferred. By using the chlorine atoms, particularly preferred reactivity can be ensured.
[0256] In the above general formula (16), R 1 As defined in the above general formulae (1) and (1').
[0257] Specific examples of the halomethyl alkyl ether compound (16) include the following compounds:
[0258] Chloromethyl alkyl ether compounds such as chloromethyl methyl ether, chloromethyl ethyl ether, chloromethyl propyl ether, chloromethyl butyl ether, chloromethyl pentyl ether, chloromethyl hexyl ether, chloromethyl heptyl ether, chloromethyl octyl ether, chloromethyl nonyl ether, and chloromethyl decyl ether;
[0259] Chloromethyl benzyl ether;
[0260] Bromomethyl alkyl ether compounds such as bromomethyl methyl ether, bromomethyl ethyl ether, bromomethyl propyl ether, bromomethyl butyl ether, bromomethyl amyl ether, bromomethyl hexyl ether, bromomethyl heptyl ether, bromomethyl octyl ether, bromomethyl nonyl ether, and bromomethyl decyl ether;
[0261] Bromomethyl benzyl ether;
[0262] Iodomethyl alkyl ether compounds such as iodomethyl methyl ether, iodomethyl ethyl ether, iodomethyl propyl ether, iodomethyl butyl ether, iodomethyl amyl ether, iodomethyl hexyl ether, iodomethyl heptyl ether, iodomethyl octyl ether, iodomethyl nonyl ether, and iodomethyl decyl ether; and
[0263] Iodomethyl benzyl ether.
[0264] Chloromethyl methyl ether, chloromethyl ethyl ether, chloromethyl propyl ether, chloromethyl butyl ether, and chloromethyl benzyl ether are preferred. By using the chloromethyl methyl ether, chloromethyl ethyl ether, chloromethyl propyl ether, chloromethyl butyl ether, and chloromethyl benzyl ether, preferred availability can be ensured. Chloromethyl methyl ether and chloromethyl ethyl ether are more preferred. By using the chloromethyl methyl ether and chloromethyl ethyl ether, more preferred availability can be ensured.
[0265] The halomethyl alkyl ether compound (16) may be commercially available, or may be synthesized on its own (eg, see Example 5 below).
[0266] The amount of the halomethyl alkyl ether compound (16) used is preferably 1.0 to 3.0 mol, more preferably 1.0 to 1.8 mol, per mol of the 4-halogeno-1-pentanol compound (15). By using the preferred amount and the more preferred amount, preferred reaction completion and more preferred reaction completion can be ensured.
[0267] If desired, a base may be incorporated into the alkoxymethylation reaction.
[0268] Examples of the base include amines such as triethylamine, N,N-diisopropylethylamine, piperidine, pyrrolidine, pyridine, lutidine, 4-dimethylaminopyridine, N,N-dimethylaniline, N,N-diethylaniline, N,N-dipropylaniline, N,N-dibutylaniline, and 1,8-diazabicyclo[5.4.0]-7-undecene (DBU).
[0269] If necessary, a base may be used alone or in combination. The base may be a commercially available base.
[0270] The amount of the base used is preferably 0.1 to 4.0 mol, more preferably 1.0 to 2.5 mol, per mol of the 4-halogeno-1-pentanol compound (15). By using the preferred amount and the more preferred amount, a preferred yield and economy and a more preferred yield and economy can be ensured.
[0271] If desired, a solvent may be incorporated in the alkoxymethylation.
[0272] Examples of the solvent include general solvents, such as ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform; and ester solvents such as methyl acetate, ethyl acetate, n-propyl acetate and n-butyl acetate. Preferred hydrocarbon solvents such as toluene and xylene; and ester solvents such as methyl acetate and ethyl acetate. By using the hydrocarbon solvents such as toluene and xylene; and ester solvents such as methyl acetate and ethyl acetate, preferred reactivity can be ensured. The above-mentioned alkoxymethylation can be carried out in the absence of a solvent in order to avoid a decrease in the ease of preparation.
[0273] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0274] When a solvent is incorporated in the alkoxymethylation, the amount of the solvent used is preferably greater than 0 to 1500 g per mol of the 4-halogeno-1-pentanol compound (15).
[0275] The reaction temperature of alkoxymethylation varies depending on the production scale, and is preferably -15 to 60° C., more preferably 10 to 40° C. By using the preferred reaction temperature and the more preferred reaction temperature, preferred reactivity and more preferred reactivity can be ensured.
[0276] The reaction time of the alkoxymethylation varies depending on the solvent used and / or the production scale, but is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0277] IV. Method for preparing 4,6,8,10,16-pentamethyldocosane (11)
[0278] A target compound of the present invention, 4,6,8,10,16-pentamethyldocosane of the following general formula (11), is prepared from the above-mentioned nucleophilic reagent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2:n=3) according to the preparation method of the following chemical reaction formula:
[0279]
[0280] Specifically, a nucleophilic 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) is subjected to a coupling reaction with a 1-halogeno-2-methylpentane compound (5) to form a 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6). The 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) is subjected to a dealkoxymethylation reaction to form a 4,6,8,10-tetramethyltridecyl alcohol (7). The 4,6,8,10-tetramethyltridecyl alcohol (7) is then subjected to a halogenation reaction to form a 1-halogeno-4,6,8,10-tetramethyltridecyl compound (8). The 1-halogeno-4,6,8,10-tetramethyltridecyl compound (8) is then converted into a nucleophilic 4,6,8,10-tetramethyltridecyl compound (9). The nucleophile 4,6,8,10-tetramethyltridecyl compound (9) is then coupled with the 1-halogeno-3-methylnonane compound (10) to give 4,6,8,10,16-pentamethyldocosane (11).
[0281] (i) Method for preparing 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6)
[0282] (a) The above-mentioned 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) will be described in detail below.
[0283] The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) is represented by the following general formula (6):
[0284]
[0285] In the above general formula (6), R 1 As defined in the above general formulas (1) and (1'). 1 When it is an n-alkyl group, R 1 It has 1 to 9 carbon atoms, preferably 1 to 4 carbon atoms.
[0286] Specific examples of the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) include 4,6,8,10-tetramethyltridecylmethoxymethyl ether, 4,6,8,10-tetramethyltridecylethoxymethyl ether, 4,6,8,10-tetramethyltridecylpropoxymethyl ether, 4,6,8,10-tetramethyltridecylbutoxymethyl ether, 4,6,8,10-tetramethyltridecylpentyloxymethyl ether, 4,6,8,10-tetramethyltridecylhexyloxymethyl ether, 4,6,8,10-tetramethyltridecylheptyloxymethyl ether, 4,6,8,10-tetramethyltridecyloctyloxymethyl ether, 4,6,8,10-tetramethyltridecylnonyloxymethyl ether, 4,6,8,10-tetramethyltridecyldecyloxymethyl ether, and 4,6,8,10-tetramethyltridecylbenzyloxymethyl ether.
[0287] (b) The method for preparing the above-mentioned 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) will be described in detail below.
[0288] The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) can be prepared, for example, from a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound of the following general formula (2: n=3) and a 1-halogeno-2-methylpentane compound of the following general formula (5), as shown in the following chemical reaction formula:
[0289]
[0290] The preparation method comprises the steps of coupling a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) with a 1-halogeno-2-methylpentane compound (5).
[0291] Hereinafter, the above-mentioned nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) will be described in detail.
[0292] The nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2:n=3) is represented by the following general formula (2:n=3):
[0293]
[0294] In the above general formula (2:n=3), M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , and Z 1 represents a halogen atom or an 8-alkoxymethoxy-1,3,5-trimethyloctyl group. Halogen atom Z 1Examples of include chlorine atoms, bromine atoms, and iodine atoms. Chlorine atoms and bromine atoms are preferred. By using the chlorine atoms and bromine atoms, preferred reactivity can be ensured. Chlorine atoms are particularly preferred. By using the chlorine atoms, particularly preferred reactivity can be ensured.
[0295] When M 1 is MgZ in the above general formula (2:n=3) 1 When the nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2:n=3:M 1B =MgZ 1B ) is a Grignard reagent.
[0296] Specific examples of the nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2:n=3) include the following examples:
[0297] 8-Alkoxymethoxy-1,3,5-trimethyloctyl lithium reagents, such as 8-methoxymethoxy-1,3,5-trimethyloctyl lithium, 8-ethoxymethoxy-1,3,5-trimethyloctyl lithium, 8-propoxymethoxy-1,3,5-trimethyloctyl lithium, and 8-butoxymethoxy-1,3,5-trimethyloctyl lithium;
[0298] 8-Alkoxymethoxy-1,3,5-trimethyloctyl magnesium halide reagent (when M 1 =MgZ 18-methoxymethoxy-1,3,5-trimethyloctyl magnesium chloride, 8-ethoxymethoxy-1,3,5-trimethyloctyl magnesium chloride, 8-propoxymethoxy-1,3,5,-trimethyloctyl magnesium chloride, 8-butoxymethoxy-1,3,5-trimethyloctyl magnesium chloride, 8-pentylmethoxy-1,3,5-trimethyloctyl magnesium chloride, 8-hexylmethoxy-1,3,5-trimethyloctyl magnesium chloride, 8-heptylmethoxy-1,3,5-trimethyloctyl magnesium bromide, 8-octylmethoxy-1 ,3,5-trimethyloctylmagnesium chloride, 8-nonylmethoxy-1,3,5-trimethyloctylmagnesium chloride, 8-benzylmethoxy-1,3,5-trimethyloctylmagnesium chloride, 8-methoxymethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-ethoxymethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-propoxymethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-butoxymethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-pentylmethoxy-1,3,5-trimethyloctylmagnesium bromide, 8 -Hexylmethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-heptylmethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-octylmethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-nonylmethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-benzylmethoxy-1,3,5-trimethyloctylmagnesium bromide, 8-methoxymethoxy-1,3,5-trimethyloctylmagnesium iodide, 8-ethoxymethoxy-1,3,5-trimethyloctylmagnesium iodide, 8-propoxymethoxy-1,3,5-trimethyl 8-octyl magnesium iodide, 8-butoxymethoxy-1,3,5-trimethyloctyl magnesium iodide, 8-pentylmethoxy-1,3,5-trimethyloctyl magnesium iodide, 8-hexylmethoxy-1,3,5-trimethyloctyl magnesium iodide, 8-heptyloxymethylthio-1,3,5-trimethyloctyl magnesium iodide, 8-octyloxymethoxy-1,3,5-trimethyloctyl magnesium iodide, 8-nonyloxymethoxy-1,3,5-trimethyloctyl magnesium iodide, and 8-benzyloxymethoxy-1,3,5-trimethyloctyl magnesium iodide (i.e., Grignard reagent);
[0299] Bis[8-alkoxymethoxy-1,3,5-trimethyloctyl] cuprate (when M 1 =CuZ 1 bis[8-methoxymethoxy-1,3,5-trimethyloctyl] cuprate, bis[8-ethoxymethoxy-1,3,5-trimethyloctyl] cuprate, bis[8-propoxymethoxy-1,3,5-trimethyloctyl] cuprate, and bis[8-butoxymethoxy-1,3,5-trimethyloctyl] cuprate; and
[0300] Gilman reagent (when M 1 =CuLiZ 1When), such as bis[8-alkoxymethoxy-1,3,5-trimethyloctyl]copperate lithium, such as bis[8-methoxymethoxy-1,3,5-trimethyloctyl]copperate lithium, bis[8-ethoxymethoxy-1,3,5-trimethyloctyl]copperate lithium, bis[8-propoxymethoxy-1,3,5-trimethyloctyl]copperate lithium, and bis[8-butoxymethoxy-1,3,5-trimethyloctyl]copperate lithium (i.e., Gilman reagent).
[0301] A Grignard reagent such as 8-alkoxymethoxy-1,3,5-trimethyloctyl magnesium halide is preferred. By using the Grignard reagent such as 8-alkoxymethoxy-1,3,5-trimethyloctyl magnesium halide, preferred reactivity can be ensured.
[0302] Hereinafter, the above-mentioned 1-halogeno-2-methylpentane compound (5) will be described in detail.
[0303] The 1-halogeno-2-methylpentane compound (5) is represented by the following general formula (5):
[0304]
[0305] In the above general formula (5), X 2 represents a halogen atom. Halogen atom X 2 Examples include chlorine atoms, bromine atoms, and iodine atoms. Bromine atoms and iodine atoms are preferred. By using the bromine atoms and iodine atoms, preferred reactivity can be ensured. Bromine atoms are particularly preferred. By using the bromine atoms, particularly preferred reactivity can be ensured.
[0306] Specific examples of the 1-halogenated 2-methylpentane compound (5) include 1-chloro-2-methylpentane, 1-bromo-2-methylpentane and 1-iodo-2-methylpentane. 1-bromo-2-methylpentane and 1-iodo-2-methylpentane are preferred. By using the 1-bromo-2-methylpentane and 1-iodo-2-methylpentane, a preferred yield can be ensured.
[0307] If necessary, the 1-halogeno-2-methylpentane compound (5) may be used alone or in combination. The 1-halogeno-2-methylpentane compound (5) may be commercially available, or may be synthesized by itself.
[0308] The 1-halogeno-2-methylpentane compound (5) can be produced, for example, by subjecting 2-methylpentanol to a halogenation reaction.
[0309] The coupling reaction of the nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) and the 1-halogeno-2-methylpentane compound (5) will be described in detail below.
[0310] The amount of the nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n = 3) used in the coupling reaction is preferably 0.8 to 1.4 mol per mol of the 1-halogeno-2-methylpentane compound (5). By using the preferred amount, preferred economy can be ensured.
[0311] If desired, a solvent may be incorporated into the coupling reaction.
[0312] Examples of the solvent include general solvents, such as ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; and polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform. Preferred hydrocarbon solvents are toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile. By using the hydrocarbon solvents such as toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile, preferred reactivity can be ensured. Tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene are more preferred. By using the tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene, more preferred reactivity can be ensured.
[0313] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0314] The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mol of the 1-halogeno-2-methylpentane compound (5). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0315] If necessary, the coupling reaction can be carried out in the presence of a catalyst. Examples of catalysts include cuprous halides such as cuprous chloride, cuprous bromide and cuprous iodide; and cupric halides such as cupric chloride, cupric bromide and cupric iodide. Cuprous halides are preferred. By using the cuprous halides, preferred reactivity can be ensured. More preferred cuprous iodide. By using the cuprous iodide, more preferred reactivity can be ensured.
[0316] If necessary, a catalyst may be used alone or in combination. The catalyst may be a commercially available catalyst.
[0317] The amount of the catalyst used is preferably 0.0003 to 0.3 mol, more preferably 0.001 to 0.1 mol, per mol of 1-halogeno-2-methylpentane compound (5). By using the preferred amount and the more preferred amount, a preferred reaction rate and / or post-treatment and a more preferred reaction rate and / or post-treatment can be ensured.
[0318] When the coupling reaction is carried out in the presence of the catalyst, a co-catalyst may be added if necessary. Examples of co-catalysts include phosphorus compounds, such as trialkyl phosphites having 3 to 9 carbon atoms, such as triethyl phosphite; and triaryl phosphine compounds having 18 to 21 carbon atoms, such as triphenylphosphine. Trialkyl phosphites are preferred. By using the trialkyl phosphites, preferred reactivity can be ensured.
[0319] If necessary, a co-catalyst may be used alone or in combination. The co-catalyst may be a commercially available co-catalyst.
[0320] The amount of the co-catalyst to be used is preferably 0.001 to 0.500 mol, more preferably 0.005 to 0.200 mol, per mol of the 1-halogeno-2-methylpentane compound (5). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0321] When the coupling reaction is carried out in the presence of the catalyst, lithium halide may be added, if necessary.
[0322] Examples of lithium halides include lithium chloride, lithium bromide, and lithium iodide. Lithium chloride is preferred. By using the lithium chloride, preferred reactivity can be ensured.
[0323] The amount of the lithium halide used in the coupling reaction is preferably 0.005 to 0.250 mol per mol of the 1-halogeno-2-methylpentane compound (5). By using the preferred amount, preferred reactivity can be ensured.
[0324] The reaction temperature of the coupling reaction varies depending on the nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2:n=3) used, and is preferably -78 to 70° C., more preferably -20 to 50° C., and most preferably 5 to 35° C. By using the preferred reaction temperature, the more preferred reaction temperature, and the most preferred reaction temperature, preferred reactivity, more preferred reactivity, and most preferred reactivity can be ensured.
[0325] The reaction time of the coupling reaction varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0326] (ii) () Method for preparing 4,6,8,10-tetramethyltridecanol (7)
[0327] Hereinafter, the method for preparing 4,6,8,10-tetramethyltridecanol (7) will be explained in detail.
[0328] 4,6,8,10-Tetramethyltridecanol (7) can be prepared, for example, from the above-mentioned 4,6,8,10-tetramethyltridecanol alkoxymethyl ether compound (6), as shown in the following chemical reaction formula:
[0329]
[0330] The preparation method comprises the step of subjecting a 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) to a dealkoxymethylation reaction.
[0331] The optimal conditions for dealkoxymethylation are as follows: 1 When R 1 When R is a phenyl group, dealkoxymethylation can be carried out, for example, under Birch reduction conditions using sodium in liquid ammonia. 1 In the case of a hydrogen atom or an n-alkyl group such as a methyl group, an ethyl group, a propyl group or a butyl group, dealkoxymethylation can be performed using an acid, water or an alcohol compound (17).
[0332] Examples of the above acid include inorganic acids such as hydrochloric acid and hydrobromic acid; sulfonic acids such as p-toluenesulfonic acid and benzenesulfonic acid; organic acids such as trifluoroacetic acid, acetic acid, formic acid and oxalic acid; and Lewis acids such as iodotrimethylsilane and titanium tetrachloride. P-toluenesulfonic acid, benzenesulfonic acid, hydrochloric acid and hydrobromic acid are preferred. By using the p-toluenesulfonic acid, benzenesulfonic acid, hydrochloric acid and hydrobromic acid, preferred side reaction suppression can be ensured. P-toluenesulfonic acid, hydrochloric acid and hydrobromic acid are particularly preferred. By using the p-toluenesulfonic acid, hydrochloric acid and hydrobromic acid, particularly preferred side reaction suppression can be ensured.
[0333] If necessary, an acid may be used alone or in combination. The acid may be a commercially available acid.
[0334] The amount of the acid to be used is preferably 0.0001 to 10.0 mol, more preferably 0.001 to 1.0 mol, per mol of the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6).
[0335] The alcohol compound (17) is represented by the following general formula (17):
[0336] R 4 OH(17)
[0337] R 4Represents a monovalent hydrocarbon group having 1 to 15 carbon atoms, preferably 1 to 6 carbon atoms. Preferably, the monovalent hydrocarbon group has 1 to 6 carbon atoms. By using the monovalent hydrocarbon group having 1 to 6 carbon atoms, the preferred price or availability can be ensured. Examples of monovalent hydrocarbon groups include straight-chain saturated hydrocarbon groups such as methyl groups, ethyl groups, n-propyl groups, n-butyl groups, n-pentyl groups, n-hexyl groups, n-heptyl groups, n-octyl groups, n-nonyl groups, n-decyl groups, n-undecyl groups and n-dodecyl groups; branched saturated hydrocarbon groups such as isopropyl groups, sec-butyl groups and 2-methylbutyl groups; straight-chain unsaturated hydrocarbon groups such as 2-propenyl groups; branched unsaturated hydrocarbon groups such as 2-methyl-2-propenyl groups; cyclic saturated hydrocarbon groups such as cyclopropyl groups; and isomers thereof. A portion of the hydrogen atoms in the hydrocarbon group may be substituted by a methyl group, an ethyl group or a hydroxyl group.
[0338] The monovalent hydrocarbon group is preferably a methyl group, an ethyl group, an n-propyl group and an n-butyl group. By using the methyl group, the ethyl group, the n-propyl group and the n-butyl group, it is possible to ensure the preferred ease of handling of the alcohol compound (17) (including, for example, the price and easy removal due to the low boiling point) and / or the amount of the starting material due to the use of the alcohol compound.
[0339] Examples of the alcohol compound (17) include straight-chain alcohols such as methanol, ethanol, n-propanol, n-butanol, n-pentanol, n-hexanol, n-heptanol, n-octanol, n-nonanol, n-decanol, n-undecanol, n-dodecanol, n-tridecanol, n-tetradecanol, and n-pentadecanol; branched alcohols such as isopropanol and 2-butanol; and diols such as ethylene glycol, propylene glycol, 2-methyl-1,3-propanediol, 2,2-dimethyl-1,3-butanediol, 1,2-dimethyl-1,3-propanediol, 1,3-dimethyl-1,3-propanediol, and 2-methyl-1,4-butanediol. Methanol and ethanol are preferred. By using the methanol and ethanol, preferred reactivity can be ensured. Methanol is particularly preferred. By using the methanol, particularly preferred reactivity can be ensured.
[0340] If necessary, the alcohol compound (17) may be used alone or in combination. The alcohol compound (17) may be a commercially available alcohol compound.
[0341] The amount of the alcohol compound (17) used is preferably 1 to 1000 mol, more preferably 1 to 100 mol, per mol of the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0342] When water is used, the amount of water used is preferably greater than 0 to 1000 mol, more preferably greater than 0 to 100 mol, per mol of the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0343] If necessary, a solvent other than the alcohol compound (17) may be incorporated in the dealkoxymethylation reaction.
[0344] Examples of the solvent include general solvents, for example, ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform; ester solvents such as methyl acetate, ethyl acetate, n-propyl acetate and n-butyl acetate; and water.
[0345] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0346] When a solvent is incorporated in the dealkoxymethylation reaction, the amount of the solvent used is preferably greater than 0 to 2000 g, more preferably greater than 0 to 500 g, per mol of the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6).
[0347] The solvent may occupy a portion of the reactor space, which reduces the space for the feedstock and reduces the productivity. Therefore, the dealkoxymethylation can be carried out without a solvent.
[0348] The reaction temperature of the dealkoxymethylation reaction varies depending on the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) used, and is preferably -5 to 180° C., more preferably 10 to 130° C. By using the preferred reaction temperature and the more preferred reaction temperature, preferred reactivity and more preferred reactivity can be ensured.
[0349] The reaction time of the dealkoxymethylation reaction varies depending on the 4,6,8,10-tetramethyltridecylalkoxymethyl ether compound (6) used or the production scale, but is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0350] In the dealkoxymethylation reaction, if necessary, the by-product alkoxymethoxymethane can be distilled off from the reaction system. By removing the alkoxymethoxymethane from the reaction system, the equilibrium can be shifted to the product side to reduce the reaction time.
[0351] (iii) 1-halogenated-4,6,8,10-tetramethyltridecane compound (8) and method for preparing 1-halogenated-4,6,8,10-tetramethyltridecane compound (8)
[0352] (a) The above-mentioned 1-halogeno-4,6,8,10-tetramethyltridecane compound (8) will be described in detail below.
[0353] The 1-halogeno-4,6,8,10-tetramethyltridecane compound (8) is represented by the following general formula (8):
[0354]
[0355] Where X 3 represents a halogen atom.
[0356] In the above general formula (8), X 3 represents a halogen atom. Halogen atom X 3 Examples of include chlorine atoms, bromine atoms, and iodine atoms. Chlorine atoms and bromine atoms are preferred. By using the chlorine atoms and bromine atoms, preferred reactivity can be ensured. Chlorine atoms are particularly preferred. By using the chlorine atoms, particularly preferred reactivity can be ensured.
[0357] (b) The method for preparing the above-mentioned 1-halogeno-4,6,8,10-tetramethyltridecane compound (8) will be described in detail below.
[0358] The 1-halogeno-4,6,8,10-tetramethyltridecane compound (8) can be prepared, for example, from 4,6,8,10-tetramethyltridecane of the following general formula (7), as shown in the following chemical reaction formula:
[0359]
[0360] The preparation method comprises the step of subjecting 4,6,8,10-tetramethyltridecanol (7) to a halogenation reaction.
[0361] The halogenation reaction can be carried out, for example, by tosylation of the hydroxyl group with a p-toluenesulfonyl halide compound and then halogenation with a metal salt lithium halide compound; or by directly halogenating the hydroxyl group with a halogenating agent.
[0362] Examples of the halogenating agent include halogens such as chlorine, bromine and iodine; hydrogen halide compounds such as hydrogen chloride, hydrogen bromide and hydrogen iodide; methanesulfonyl halide compounds such as methanesulfonyl chloride, methanesulfonyl bromide and methanesulfonyl iodide; benzenesulfonyl halide compounds such as benzenesulfonyl chloride, benzenesulfonyl bromide and benzenesulfonyl iodide; p-toluenesulfonyl halide compounds such as p-toluenesulfonyl chloride, p-toluenesulfonyl bromide and p-toluenesulfonyl iodide; thionyl halide compounds such as thionyl chloride, thionyl bromide and thionyl iodide; phosphorus halide compounds such as phosphorus trichloride, phosphorus pentachloride and phosphorus tribromide; carbon tetrahalide compounds such as carbon tetrachloride, carbon tetrabromide and carbon tetraiodide; alkylsilyl halide compounds such as trimethylol Silyl chloride, trimethylsilyl bromide, trimethylsilyl iodide, triethylsilyl chloride, triethylsilyl bromide, triethylsilyl iodide, triisopropylsilyl chloride, triisopropylsilyl bromide, triisopropylsilyl iodide, tert-butyldimethylsilyl chloride, tert-butyldimethylsilyl bromide and tert-butyldimethylsilyl iodide; oxalyl halide compounds such as oxalyl chloride, oxalyl bromide and oxalyl iodide; and N-halogenated succinimide compounds such as N-chlorosuccinimide, N-bromosuccinimide and N-iodosuccinimide. Preferred are methanesulfonyl halide compounds, benzenesulfonyl halide compounds, p-toluenesulfonyl halide compounds and thionyl halide compounds. By using the methanesulfonyl halide compound, benzenesulfonyl halide compound, p-toluenesulfonyl halide compound and thionyl halide compound, preferred side reaction suppression can be ensured. Methanesulfonyl halide compound, benzenesulfonyl halide compound and thionyl halide compound are particularly preferred. By using the methanesulfonyl halide compound, benzenesulfonyl halide compound and thionyl halide compound, particularly preferred side reaction suppression can be ensured.
[0363] If necessary, a halogenating agent may be used alone or in combination. The halogenating agent may be a commercially available halogenating agent.
[0364] The amount of the halogenating agent used is preferably 0.8 to 5.0 mol, more preferably 1.0 to 2.5 mol, per mol of the 4,6,8,10-tetramethyltridecanol (7). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0365] If necessary, a base may be incorporated in the halogenation reaction.
[0366] Examples of the base include hydroxides such as sodium hydroxide, potassium hydroxide, calcium hydroxide and magnesium hydroxide; carbonates such as sodium carbonate, potassium carbonate, calcium carbonate and magnesium carbonate; and amines such as triethylamine, N,N-diisopropylethylamine, piperidine, pyrrolidine, pyridine, lutidine, 4-dimethylaminopyridine, N,N-dimethylaniline, N,N-diethylaniline and 1,8-diazabicyclo[5.4.0]-7-undecene (DBU).
[0367] When a methanesulfonyl halide compound, a benzenesulfonyl halide compound, a p-toluenesulfonyl halide compound or the like is used as the halogenating agent, the base is preferably an amine, more preferably a pyridine such as pyridine, lutidine and 4-dimethylaminopyridine.
[0368] When a thionyl chloride compound is used as the halogenating agent, the base is preferably an amine, more preferably a trialkylamine such as triethylamine.
[0369] If necessary, a base may be used alone or in combination. The base may be a commercially available base.
[0370] When a base is used, the amount of the base used is preferably greater than 0 to 8.0 mol, more preferably greater than 0 to 3.0 mol, per mol of the 4,6,8,10-tetramethyltridecanol (7). By using the preferred amount and the more preferred amount, a preferred yield and / or economy and a more preferred yield and / or economy can be ensured.
[0371] If desired, a metal salt may be incorporated into the halogenation reaction.
[0372] Examples of the metal salt include lithium salts such as lithium chloride, lithium bromide and lithium iodide; sodium salts such as sodium chloride, sodium bromide and sodium iodide; potassium salts such as potassium chloride, potassium bromide and potassium iodide; calcium salts such as calcium chloride, calcium bromide and calcium iodide; and magnesium salts such as magnesium chloride, magnesium bromide and magnesium iodide.
[0373] When halogenation is carried out using a metal salt lithium halide compound after tosylation, for example, the reaction can be carried out using a lithium salt such as lithium chloride, lithium bromide and lithium iodide.
[0374] If necessary, metal salts may be used alone or in combination. The metal salt may be a commercially available metal salt.
[0375] When a metal salt is used, the amount of the metal salt used is preferably greater than 0 to 30.0 mol, more preferably greater than 0 to 5.0 mol, per mol of the 4,6,8,10-tetramethyltridecanol (7). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0376] Although metal salts increase the concentration of halide ions in the reaction system, thereby improving reactivity, it is preferred not to add metal salts to the reaction. By not adding metal salts, preferred economical properties and / or environmental protection can be ensured.
[0377] If necessary, a solvent may be incorporated in the halogenation reaction.
[0378] Examples of the solvent include general solvents, for example, ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, acetone, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform; and ester solvents such as methyl acetate, ethyl acetate, n-propyl acetate and n-butyl acetate. Preferred are 2-methyltetrahydrofuran, 4-methyltetrahydropyran, dichloromethane, chloroform, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and acetonitrile. By using the 2-methyltetrahydrofuran, 4-methyltetrahydropyran, dichloromethane, chloroform, γ-butyrolactone, N-methylpyrrolidone, N,N-dimethylformamide, N,N-dimethylacetamide, and acetonitrile, preferred reactivity can be ensured. 2-methyltetrahydrofuran, γ-butyrolactone and acetonitrile are particularly preferred. By using the 2-methyltetrahydrofuran, γ-butyrolactone and acetonitrile, particularly preferred safety can be ensured.
[0379] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0380] When the solvent is incorporated in the halogenation reaction, the amount of the solvent used is preferably greater than 0 to 3000 g, more preferably greater than 0 to 800 g, per mol of the 4,6,8,10-tetramethyltridecanol (7).
[0381] The solvent may occupy a portion of the reactor space, which reduces the space for the raw materials and reduces the productivity. Therefore, the reaction can be carried out without a solvent or using a base as a solvent.
[0382] The reaction temperature of the halogenation reaction varies depending on the halogenating agent used, and is preferably 5 to 180° C., more preferably 20 to 120° C. By using the preferred reaction temperature and the more preferred reaction temperature, preferred reactivity and more preferred reactivity can be ensured.
[0383] The reaction time of the halogenation reaction varies depending on the halogenating agent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0384] (iv) Nucleophile 4,6,8,10-tetramethyltridecyl compound (9) and method for preparing nucleophile 4,6,8,10-tetramethyltridecyl compound (9)
[0385] Hereinafter, a method for preparing the above-mentioned nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) will be explained in detail.
[0386] (a) The nucleophile 4,6,8,10-tetramethyltridecyl compound (9) will be described in detail below.
[0387] The nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) is represented by the following general formula (9):
[0388]
[0389] In the above general formula (9), M 2 Indicates Li, MgZ 2 ,CuZ 2 or CuLiZ 2 , Z 2 represents a halogen atom or a 4,6,8,10-tetramethyltridecyl group. Halogen atom Z 2 Examples of include a chlorine atom, a bromine atom and an iodine atom.
[0390] Specific examples of the nucleophilic reagent 4,6,8,10-tetramethyltridecyl compound (9) include 4,6,8,10-tetramethyltridecyl lithium; 4,6,8,10-tetramethyltridecyl magnesium halide reagent (when M 2 =MgZ 2 When M 2 =CuZ 2 and Gilman reagent (when M 2 =CuLiZ 2 When (when) such as bis[4,6,8,10-tetramethyltridecyl] lithium cuprate (i.e., Gilman reagent). Preferably, a Grignard reagent such as 4,6,8,10-tetramethyltridecyl magnesium halide reagent is used. By using the Grignard reagent such as 4,6,8,10-tetramethyltridecyl magnesium halide reagent, preferred reactivity can be ensured.
[0391] (b) The method for preparing the above-mentioned nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) will be described in detail below.
[0392] The nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) can be prepared by a conventional method or the following method.
[0393]
[0394] The preparation of the nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) will be described in detail as an example, wherein M 2 MgZ 2 , namely 4,6,8,10-tetramethyltridecylmagnesium halide reagent (9:M 2 =MgZ 2 ) (i.e., Grignard reagent) method.
[0395] 4,6,8,10-Tetramethyltridecylmagnesium halide reagent (9:M 2 =MgZ 2 , Z 2 = halogen atom) can be prepared by, for example, reacting the above-mentioned 1-halogeno-4,6,8,10-tetramethyltridecane compound (8) with magnesium in a solvent, as shown in the following chemical reaction formula:
[0396]
[0397] The amount of magnesium used is preferably 1.0 to 2.0 gram atoms per mol of the 1-halogeno-4,6,8,10-tetramethyltridecane compound (8). By using the preferred amount, it is possible to ensure that the preferred reaction is completed.
[0398] Examples of solvents include general solvents, for example, ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; and hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and isopropylbenzene. Preferred hydrocarbon solvents are toluene and xylene; and ether solvents are tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran. By using the hydrocarbon solvents such as toluene and xylene; and ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran, the preferred reaction rate for forming the above-mentioned Grignard reagent can be ensured. More preferred are tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran. By using the tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran, the preferred reaction rate for forming the above-mentioned Grignard reagent can be ensured.
[0399] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0400] The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g per mol of the 1-halogeno-4,6,8,10-tetramethyltridecane compound (8). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0401] The reaction temperature varies depending on the solvent used, but is preferably 30 to 120° C. By using the preferred reaction temperature, preferred reactivity can be ensured.
[0402] The reaction time varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0403] (v) 4,6,8,10,16-pentamethyldocosane (11) and method for preparing 4,6,8,10,16-pentamethyldocosane (11)
[0404] (a) The 4,6,8,10,16-pentamethyldocosane (11) will be described in detail below.
[0405] The 4,6,8,10,16-pentamethyldocosane (11) is represented by the following general formula (11):
[0406]
[0407] (b) The method for preparing the above-mentioned 4,6,8,10,16-pentamethyldocosane (11) will be explained in detail below.
[0408] 4,6,8,10,16-pentamethyldocosane (11) can be prepared, for example, from a nucleophilic agent 4,6,8,10-tetramethyltridecyl compound of the following general formula (9) and a 1-halogeno-3-methylnonane compound of the following general formula (10), as shown in the following chemical reaction formula:
[0409]
[0410] The preparation method comprises the steps of coupling a nucleophilic reagent 4,6,8,10-tetramethyltridecyl compound (9) with a 1-halogeno-3-methylnonane compound (10).
[0411] Hereinafter, the above-mentioned 1-halogeno-3-methylnonane compound (10) will be described in detail.
[0412] The 1-halogeno-3-methylnonane compound (10) is represented by the following general formula (10):
[0413]
[0414] In the above general formula (10), X 4 represents a halogen atom. Halogen atom X 4 Examples include chlorine atoms, bromine atoms, and iodine atoms. Bromine atoms and iodine atoms are preferred. By using the bromine atoms and iodine atoms, preferred reactivity can be ensured. Bromine atoms are particularly preferred. By using the bromine atoms, particularly preferred reactivity can be ensured.
[0415] Specific examples of the 1-halogenated 3-methylnonane compound (10) include 1-chloro-3-methylnonane, 1-bromo-3-methylnonane and 1-iodo-3-methylnonane. 1-bromo-3-methylnonane and 1-iodo-3-methylnonane are preferred. By using the 1-bromo-3-methylnonane and 1-iodo-3-methylnonane, a preferred yield can be ensured.
[0416] If necessary, the 1-halogeno-3-methylnonane compound (10) may be used alone or in combination. The 1-halogeno-3-methylnonane compound (10) may be commercially available or may be synthesized by itself.
[0417] The 1-halogeno-3-methylnonane compound (10) can be produced, for example, by subjecting 3-methylnonanol to a halogenation reaction.
[0418] The coupling reaction of the nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) and the 1-halogeno-3-methylnonane compound (10) will be described in detail below.
[0419] The amount of the nucleophile 4,6,8,10-tetramethyltridecyl compound (9) used in the coupling reaction is preferably 0.8 to 1.4 mol per mol of the 1-halogeno-3-methylnonane compound (10). By using the preferred amount, preferred economy can be ensured.
[0420] If desired, a solvent may be incorporated into the coupling reaction.
[0421] Examples of the solvent include general solvents, such as ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), diethyl ether, butyl ether, 4-methyltetrahydropyran (MTHP), cyclopentyl methyl ether and 1,4-dioxane; hydrocarbon solvents such as hexane, heptane, benzene, toluene, xylene and cumene; and polar solvents such as N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), dimethyl sulfoxide (DMSO), γ-butyrolactone (GBL), acetonitrile, N,N'-dimethylpropylene urea (DMPU), hexamethylphosphoric acid triamide (HMPA), dichloromethane and chloroform. Preferred hydrocarbon solvents are toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile. By using the hydrocarbon solvents such as toluene and xylene; ether solvents such as tetrahydrofuran, 2-methyltetrahydrofuran and 4-methyltetrahydropyran; and acetonitrile, preferred reactivity can be ensured. Tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene are more preferred. By using the tetrahydrofuran, 2-methyltetrahydrofuran, toluene and xylene, more preferred reactivity can be ensured.
[0422] If necessary, solvents may be used alone or in combination. The solvent may be a commercially available solvent.
[0423] The amount of the solvent used is preferably 30 to 5000 g, more preferably 50 to 3000 g, per mol of the 1-halogeno-3-methylnonane compound (10). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0424] If necessary, the coupling reaction can be carried out in the presence of a catalyst. Examples of catalysts include cuprous halides such as cuprous chloride, cuprous bromide and cuprous iodide; and cupric halides such as cupric chloride, cupric bromide and cupric iodide. Cuprous halides are preferred. By using the cuprous halides, preferred reactivity can be ensured. More preferably cuprous chloride. By using the cuprous chloride, more preferred reactivity can be ensured.
[0425] If necessary, a catalyst may be used alone or in combination. The catalyst may be a commercially available catalyst.
[0426] The amount of the catalyst used is preferably 0.0003 to 0.3 mol, more preferably 0.001 to 0.1 mol, per mol of 1-halogeno-3-methylnonane compound (10). By using the preferred amount and the more preferred amount, a preferred reaction rate and / or post-treatment and a more preferred reaction rate and / or post-treatment can be ensured.
[0427] When the coupling reaction is carried out in the presence of the catalyst, a co-catalyst may be added if necessary. Examples of co-catalysts include phosphorus compounds, such as trialkyl phosphites having 3 to 9 carbon atoms, such as triethyl phosphite; and triaryl phosphine compounds having 18 to 21 carbon atoms, such as triphenylphosphine. Trialkyl phosphites are preferred. By using the trialkyl phosphites, preferred reactivity can be ensured.
[0428] If necessary, a co-catalyst may be used alone or in combination. The co-catalyst may be a commercially available co-catalyst.
[0429] The amount of the co-catalyst to be used is preferably 0.001 to 0.500 mol, more preferably 0.005 to 0.200 mol, per mol of the 1-halogeno-3-methylnonane compound (10). By using the preferred amount and the more preferred amount, preferred reactivity and more preferred reactivity can be ensured.
[0430] When the coupling reaction is carried out in the presence of the catalyst, lithium halide may be added, if necessary.
[0431] Examples of lithium halides include lithium chloride, lithium bromide, and lithium iodide. Lithium chloride is preferred. By using the lithium chloride, preferred reactivity can be ensured.
[0432] If necessary, lithium halides may be used alone or in combination. The lithium halide may be a commercially available lithium halide.
[0433] The amount of lithium halide used in the coupling reaction is preferably 0.005 to 0.250 mol per mol of the 1-halogeno-3-methylnonane compound (10). By using the preferred amount, preferred reactivity can be ensured.
[0434] The reaction temperature of the coupling reaction varies depending on the nucleophilic agent 4,6,8,10-tetramethyltridecyl compound (9) used, and is preferably -78 to 70° C., more preferably -20 to 50° C., and most preferably 5 to 35° C. By using the preferred reaction temperature, the more preferred reaction temperature, and the most preferred reaction temperature, preferred reactivity, more preferred reactivity, and most preferred reactivity can be ensured.
[0435] The reaction time of the coupling reaction varies depending on the solvent used and / or the production scale, and is preferably 0.5 to 100 hours. By using the preferred reaction time, preferred reactivity can be ensured.
[0436] Therefore, according to the present invention, the cuticle hydrocarbon 4,6,8,10,16-pentamethyldocosane (11) of Antitrogus parvulus can be efficiently produced from the synthetic intermediate haloalkylalkoxymethyl ether compound (2) with high ease of production and a small number of steps.
[0437] Example
[0438] The present invention is described with reference to the following examples. It should be noted that the present invention is not limited to or by these examples.
[0439] Unless otherwise indicated, the term "purity" used herein refers to the area percentage of gas chromatography (GC). The term "product ratio" refers to the ratio of the area percentage of GC. The term "yield" is calculated from the area percentage determined by GC.
[0440] In the embodiment, the reaction was monitored and the yield was calculated under the following GC conditions:
[0441] GC conditions: GC: capillary gas chromatograph GC-2014 (Shimadzu Corporation); column: DB-5, 0.25 μm × 0.25 mmφ × 30 m; carrier gas: He (1.55 mL / min), detector: FID; column temperature: 150 °C, increasing at a rate of 5 °C / min, reaching a maximum of 230 °C; column: DB-WAX, 0.25 μm × 0.25 mmφ × 30 m; carrier gas: He (1.55 mL / min), detector: FID; column temperature: 150 °C, increasing at a rate of 5 °C / min, reaching a maximum of 230 °C.
[0442] Taking into account the purity (%GC) of the starting material and the product, the yield was calculated by the following equation.
[0443] Yield (%) = {[(weight of product obtained by reaction×%GC) / molecular weight of product]÷[(weight of starting material in reaction×%GC) / molecular weight of starting material]}×100.
[0444] THF represents tetrahydrofuran, GBL represents gamma-butyrolactone, PO represents propylene oxide, Ph represents a phenyl group, and Et represents an ethyl group.
[0445] Example 1: Preparation of 8-hydroxy-4,6-dimethylnonyl methoxymethyl ether (4:n+1=3 and R 1 =H)
[0446]
[0447] Magnesium (22.66 g, 0.98 gram atoms) and tetrahydrofuran (279.72 g) were placed in a reactor at room temperature and stirred at 60 to 65° C. for 31 minutes. Then, 6-chloro-4-methylheptylmethoxymethyl ether (1:n=2, R 1 =H,X 1 =Cl) (220.00 g, 0.93 mol, purity 88.46%) was added to the reactor. After the addition was completed, the reaction mixture was stirred at 75 to 80° C. for 2 hours to obtain 6-methoxymethoxy-1,3-dimethylheptylmagnesium chloride (2: n = 2, R 1 =H,M 1 =MgCl).
[0448] Next, the internal temperature of the reactor was cooled to 0 to 10° C., and then cuprous chloride (0.19 g, 0.0019 mol) was added to the reactor, and propylene oxide was added dropwise at 5 to 30° C. After the addition was completed, the reaction mixture was stirred at 15 to 25° C. for 3 hours. Then, an acetic acid aqueous solution (prepared from acetic acid (127.25 g) and water (381.78 g)) and hexane (90.49 g) were added to the reaction mixture, and then phase separation was performed. The organic layer thus obtained was concentrated under reduced pressure, and the concentrate obtained was distilled under reduced pressure to obtain 8-hydroxy-4,6-dimethylnonylmethoxymethyl ether (4:n+1=3, R 1 =H) (182.15 g, 0.75 mol, purity 95.28%, bp = 120.0 to 127.8°C / 0.36 kPa (2.7 mmHg)), with a yield of 80.11%.
[0449] The following is the preparation of 8-hydroxy-4,6-dimethylnonyl methoxymethyl ether (4:n+1=3, R 1 =H) spectral data.
[0450] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.80-0.90(6H,m),0.90-1.14(2H,m),1.14-1.20(4H,m),1.20 -1.75(8H,m),3.34(3H,s),3.49(2H,t-like,J=6.9Hz),3.83-3.92(1H,m),4.60(2H,s); 13C-NMR (125MHz, CDCl3): δ=19.26,19.31,19.91,20.05,20.14,20.68,23.57,23.78,24.25,26.70,26.87,27.10,27.24,2 7.26,29.72,32.81,44.55,44.94,45.23,45.60,46.65,47.67,47.82,55.04,65.59,65.98,66.14,68.13,68.21,96.33.
[0451] Mass spectrum: EI-mass spectrum (70eV): m / z 231 (M + -1),201,139,97,85,69,57,45,29.
[0452] Infrared absorption spectrum: (D-ATR): ν = 2957, 2927, 1461, 1378, 1304, 1214, 1153, 1111, 1045, 920.
[0453] Example 2: Preparation of 8-chloro-4,6-dimethylnonyl methoxymethyl ether (1': n+1=3, R 1 =H,X 1 =Cl)
[0454]
[0455] The 8-hydroxy-4,6-dimethylnonyl methoxymethyl ether (4:n+1=3, R 1 =H) (85.00 g, 0.35 mol, purity 95.28%), pyridine (41.35 g, 0.52 mol) and GBL (100.00 g) were placed in a reactor and stirred at 10° C. for 26 minutes.
[0456] Then, methanesulfonyl chloride (CH3SO2Cl) (47.90 g, 0.42 mol) was added dropwise at 5 to 15°C. After the addition was completed, the reaction mixture was heated to 60 to 65°C and stirred for 9 hours. After the stirring was completed, water (87.13 g) and hexane (52.28 g) were added to the reaction mixture, and then phase separation was performed. The aqueous layer was removed to obtain an organic layer. The organic layer was washed with an acetic acid aqueous solution (prepared from acetic acid (3.67 g) and water (45.85 g)), and then washed with an aqueous sodium bicarbonate solution (prepared from sodium bicarbonate (1.83 g) and water (45.85 g). The organic layer thus obtained was concentrated under reduced pressure, and the concentrate obtained was purified by silica gel column chromatography (hexane: ethyl acetate = 100: 0 to 9: 1) to obtain 8-chloro-4,6-dimethylnonyl methoxymethyl ether (1': n+1 = 3, R 1=H,X 1 =Cl)(73.37 g, 0.27 mol, purity 93.15%), the yield was 78.19%.
[0457] The following is the preparation of 8-chloro-4,6-dimethylnonyl methoxymethyl ether (1': n+1=3, R 1 =H,X 1 =Cl).
[0458] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.83-0(6H,m),0.90-1.46(4H,m),1.46-1.90(9H,m),3.35(3H,s),3.50(2H,t,J=6.9Hz),4.06-4.14(1H,m),4.61(2H,s); 13 C-NMR (125MHz, CDCl3): δ=18.60,19.11,19.38,19.80,20.26,25.46,26.01,27.58,27.6 9,29.78,29.86,32.67,33.36,33.97,34.43,44.36,44.87,55.07,68.15,68.17,96.37.
[0459] Mass spectrum: EI-mass spectrum (70eV): m / z 249 (M + -1),236,219,205,188,151,137,123,109,83,69,45.
[0460] Infrared absorption spectrum: (D-ATR): ν = 2953, 2928, 1461, 1380, 1214, 1153, 1111, 1045, 920, 677, 616.
[0461] The 8-chloro-4,6-dimethylnonylmethoxymethyl ether (1': n+1=3, R 1 =H,X 1 =Cl) and the halogenated alkyl alkoxymethyl ether compound described in this specification (1: n = 3, R 1 =H,X 1 =Cl). Although 8-chloro-4,6-dimethylnonylmethoxymethyl ether (1': n+1 = 3, R 1 =H,X 1 =Cl) was used as the starting material in Examples 3 and 7 below, which is equivalent to using a haloalkyl alkoxymethyl ether compound (1: n = 3, R 1 =H,X 1 =Cl) as the starting material.
[0462] Example 3: Preparation of 10-hydroxy-4,6,8-trimethylundecylmethoxymethyl ether (4:n+1=4, R 1 =H)
[0463]
[0464] Magnesium (0.75 g, 0.031 gram atom) and tetrahydrofuran (8.88 g) were placed in a reactor at room temperature and stirred at 60 to 65° C. for 19 minutes. Then, 8-chloro-4,6-dimethylnonylmethoxymethyl ether (1′: n+1=3, R 1 =H,X 1 =Cl) (7.97 g, 0.030 mol, purity 93.15%) was added to the reactor. After the addition was completed, the reaction mixture was stirred at 75 to 80° C. for 3 hours to obtain 8-methoxymethoxy-1,3,5-trimethyloctylmagnesium chloride (2a: n=3, R 1 =H,M 1 =MgCl).
[0465] Next, the internal temperature of the reactor was cooled to 0 to 10° C., and then cuprous chloride (0.0062 g, 0.000059 mol) was added to the reactor, and propylene oxide (1.98 g, 0.034 mol) was added dropwise at 5 to 30° C. After the addition was completed, the reaction mixture was stirred at 15 to 25° C. for 3.5 hours. Then, an acetic acid aqueous solution (prepared from acetic acid (4.04 g) and water (32.12 g)) and hexane (2.87 g) were added to the reaction mixture, and then phase separation was performed. The organic layer thus obtained was concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography (hexane: ethyl acetate = 9: 1 to 2: 1) to obtain 10-hydroxy-4,6,8-trimethylundecylmethoxymethyl ether (4: n+1 = 4, R 1 =H) (6.94 g, 0.025 mol, purity 100%), the yield was 85.45%.
[0466] The following is the preparation of 10-hydroxy-4,6,8-trimethylundecylmethoxymethyl ether (4:n+1=4, R 1 =H) spectral data.
[0467] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.77-1.76(26H,m),3.35(3H,s),3.49(2H,t,J=6.9Hz),3.84-3.93(1H,m),4.61(2H,s); 13C-NMR (125MHz, CDCl3): δ=19.26,20.05,20.18,20.48,23.50,27.11,27.15,27.19,27.22,27.30,2 9.79,29.85,29.88,34.45,44.32,45.54,46.87,47.09,55.05,66.30,68.16,68.18,68.22,96.33.
[0468] Mass spectrum: EI-mass spectrum (70eV): m / z 273 (M + -1),227,200,139,111,69,45.
[0469] Infrared absorption spectrum: (D-ATR): ν=3440,2957,2925,1461,1378,1214,1153,1112,1045,920.
[0470] Example 4: Preparation of 10-chloro-4,6,8-trimethylundecylmethoxymethyl ether (1': n+1 = 4, R 1 =H,X 1 =Cl)
[0471]
[0472] The 10-hydroxy-4,6,8-trimethylundecylmethoxymethyl ether (4:n+1=4, R 1 =H) (5.64 g, 0.021 mol, purity 100%), pyridine (2.44 g, 0.031 mol) and GBL (15.00 g) were placed in a reactor and stirred at 10° C. for 12 minutes.
[0473] Then, methanesulfonyl chloride (CH3SO2Cl) (2.83 g, 0.025 mol) was added dropwise at 5 to 15°C. After the addition was completed, the reaction mixture was heated to 60 to 65°C and stirred for 8 hours. After the stirring was completed, water (15.15 g) and hexane (13.09 g) were added to the reaction mixture, and then phase separation was performed. The aqueous layer was removed to obtain an organic layer. The organic layer was washed with an acetic acid aqueous solution (prepared from acetic acid (0.22 g) and water (15.00 g)), and then the organic layer obtained was washed with an aqueous sodium bicarbonate solution (prepared from sodium bicarbonate (0.11 g) and water (15.00 g). The organic layer obtained was concentrated under reduced pressure, and the concentrate obtained was purified by silica gel column chromatography (hexane: ethyl acetate = 80: 0 to 5: 1) to obtain 10-chloro-4,6,8-trimethylundecylmethoxymethyl ether (1': n+1 = 4, R 1 =H,X 1=Cl) (5.56 g, 0.017 mol, purity 90.04%), the yield was 83.03%.
[0474] The following is the preparation of 10-chloro-4,6,8-trimethylundecylmethoxymethyl ether (1': n+1 = 4, R 1 =H,X 1 =Cl).
[0475] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.75-1.90(25H,m),3.36(3H,s),3.50(2H,t,J=6.9Hz),4.06-4.15(1H,m),4.61(2H,s); 13 C-NMR (125MHz, CDCl3): δ=19.35,19.78,20.24,20.46,26.27,27.10,27.11,27.22,27.2 5,27.31,27.52,27.77,29.79,29.86,29.91,32.98,45.28,55.06,68.18,68.22,96.37.
[0476] Mass spectrum: EI-mass spectrum (70eV): m / z 291 (M + -1),247,146,111,69,45.
[0477] Infrared absorption spectrum: (D-ATR): ν=2854,2927,1460,1380,1214,1153,1111,1047,968,920,677,617.
[0478] Example 5: Preparation of 8-chloro-4,6-dimethylnonylbutoxymethyl ether (1': n+1=3, R 1 =CH2CH2CH3,X 1 =Cl)
[0479]
[0480] Dibutoxymethane (3.02 g, 0.019 mol) and zinc chloride (0.02 g, 0.00018 mol) were placed in a reactor at room temperature and stirred at 15 to 25° C. for 4 minutes. Acetyl chloride (AcCl) (1.31 g, 0.017 mol) was then added dropwise to the reactor at 30 to 40° C. After the addition was complete, the reaction mixture was stirred at 38 to 42° C. for 4 hours to obtain chloromethyl butyl ether.
[0481] Then, a mixed solution of N,N-diethylaniline (2.49 g, 0.017 mol) and 8-chloro-4,6-dimethylnonanol (3.02 g, 0.015 mol, purity 99.26%) was added dropwise to the reactor at 20 to 30° C. After the addition was completed, the reaction mixture was stirred at 20 to 30° C. for 19 hours. Then, a 25% by mass aqueous solution of sodium hydroxide (2.52 g) and water (1.60 g) was added to the reaction mixture, and then phase separation was performed. The organic layer thus obtained was concentrated under reduced pressure, and the concentrate obtained was purified by silica gel column chromatography (hexane: ethyl acetate = 50:0 to 9:1) to obtain 8-chloro-4,6-dimethylnonyl butoxymethyl ether (1': n+1 = 3, R 1 =CH2CH2CH3,X 1 =Cl) (4.03 g, 0.014 mol, purity 99.99%), the yield was 94.90%.
[0482] The following is the preparation of 8-chloro-4,6-dimethylnonylbutoxymethyl ether (1': n+1=3, R 1 =CH2CH2CH3,X 1 =Cl).
[0483] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ = 0.83-0.89 (6H, m), 0.92 (3H, t, J = 7.3Hz), 1.00-1.90 (17 H,m),3.50(2H,t,J=6.9Hz),3.52(2H,t,J=6.9Hz),4.05-4.14(1H,m),4.66(2H,s); 13 C-NMR (125MHz, CDCl3): δ=13.87,19.12,19.37,19.58,19.60,19.80,25.47,26.22,27.17,27.30,27.68,27.80,29.68,2 9.79,29.86,31.80,33.39,34.00,34.45,43.62,44.84,45.17,47.34,48.44,48.78,56.63,67.51,68.08,68.13,95.25.
[0484] Mass spectrum: EI-mass spectrum (70eV): m / z 291 (M + -1),257,205,151,111,87,57.
[0485] Infrared absorption spectrum: (D-ATR): ν = 2958, 2929, 2872, 1459, 1380, 1145, 1115, 1071, 1046, 616.
[0486] Example 6: Preparation of 8-chloro-4,6-dimethylnonylbenzyloxymethyl ether (1': n+1=3, R 1 =Ph,X 1 =Cl)
[0487]
[0488] Benzyl chloromethyl ether (2.25 g, 0.013 mol, purity 90%) and toluene (4.0 g) were placed in a reactor at room temperature and stirred at 15 to 25° C. for 19 minutes. A mixture of 8-chloro-4,6-dimethylnonanol (2.95 g, 0.011 mol, purity 78.77%) and N,N-diethylaniline (1.93 g, 0.013 mol) was then added dropwise to the reactor at 20 to 30° C. After the addition was complete, the reaction mixture was stirred at 20 to 30° C. for 20 hours. A 25% aqueous solution of sodium hydroxide (2.54 g; 0.016 mol of sodium hydroxide) and water (1.61 g) was then added to the reaction mixture, followed by phase separation. The reaction mixture was washed three times with 20% hydrochloric acid (0.88 g; 0.0048 mol of hydrogen chloride). The organic layer thus obtained was concentrated, and the resulting concentrate was purified by silica gel column chromatography (hexane:ethyl acetate=50:1 to 9:1) to obtain 8-chloro-4,6-dimethylnonylbenzyloxymethyl ether (1′:n+1=3, R 1 =Ph,X 1 =Cl) (4.31 g, 0.011 mol, purity 79.80%), yield 93.60%.
[0489] The following is the preparation of 8-chloro-4,6-dimethylnonylbenzyloxymethyl ether (1': n+1=3, R 1 =Ph,X 1 =Cl).
[0490] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.80-1.90(19H,m),3.58(2H,t,J=6.9Hz),4.07-4.16(1H,m),4.61(2H,s),4.77(2H,s),7.34-7.38(5H,m); 13C-NMR (125MHz, CDCl3): δ=20.27,20.29,25.21,26.02,26.94,27.18,27.58,27.69,27.93,29.70,29.79,32.68,44.34,4 5.17,47.34,48.16,56.70,68.41,69.23,69.25,69.49,94.58,94.60,127.62,127.85,127.93,128.38,128.42,137.97.
[0491] Mass spectrum: EI-mass spectrum (70eV): m / z 326 (M + ),151,120,91,55.
[0492] Infrared absorption spectrum: (D-ATR): ν = 3031, 2953, 2927, 2872, 1497, 1455, 1379, 1208, 1169, 1113, 1048, 1028, 967, 735, 697, 614.
[0493] Example 7: Preparation of 4,6,8,10-tetramethyltridecyl methoxymethyl ether (6:R 1 =H)
[0494]
[0495] Magnesium (3.49 g, 0.14 gram atom) and tetrahydrofuran (75.13 g) were placed in a reactor at room temperature and stirred at 60 to 65° C. for 29 minutes. Then, 8-chloro-4,6-dimethylnonylmethoxymethyl ether (1′: n+1=3, R 1 =H,X 1 =Cl) (36.78 g, 0.14 mol, purity 93.15%) was added to the reactor. After the addition was completed, the reaction mixture was stirred at 75 to 80° C. for 5 hours to obtain 8-methoxymethoxy-1,3,5-trimethyloctylmagnesium chloride (2: n = 3, R 1 =H,M 1 =MgCl).
[0496] Then cuprous iodide (0.26 g, 0.0014 mol), triethyl phosphite (0.54 g, 0.0033 mol), tetrahydrofuran (162.56 g) and 1-bromo-2-methylpentane (5:X 2 =Br) (21.85 g, 0.13 mol, purity 98.05%) was placed in another reactor, and the prepared 8-methoxymethoxy-1,3,5-trimethyloctylmagnesium chloride (2: n = 3, R1 =H,M 1 =MgCl). After the dropwise addition was completed, the reaction mixture was stirred at 15 to 25°C for 2.5 hours. An acetic acid aqueous solution (prepared from acetic acid (17.07 g) and water (51.23 g)) and a 25% by mass sodium hydroxide aqueous solution (4.09 g) were then added to the reaction mixture, followed by phase separation. The organic layer thus obtained was concentrated under reduced pressure, and the resulting concentrate was purified by silica gel column chromatography (hexane:ethyl acetate=50:1 to 9:1) to obtain 4,6,8,10-tetramethyltridecylmethoxymethyl ether (6:R 1 =H) (36.09 g, 0.10 mol, purity 87.02%), the yield was 80.50%.
[0497] The following is the preparation of 4,6,8,10-tetramethyltridecyl methoxymethyl ether (6:R 1 =H) spectral data.
[0498] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ = 0.76-0.90 (16H, m), 0.90-1.43 (11H, m), 1.43-1.7 0(6H,m),1.43-1.70(6H,m),3.50(2H,t,J=6.9Hz),3.03(3H,s),4.62(2H,s); 13 C-NMR (125MHz, CDCl3): δ=14.36,14.41,19.34,19.93,19.97,20.00,20.02,20.12,20.14,20.28,20.30,20.42,20.6 6,21.01,27.10,27.20,27.24,27.27,27.31,27.39,29.73,29.76,29.82,33.02,40.56,46.12,55.06,68.22,68.26.
[0499] Mass spectrum: EI-mass spectrum (70eV): m / z 299 (M + -1),269,255,239,225,199,185,171,155,141,125,111,85,69,45.
[0500] Infrared absorption spectrum: (D-ATR): ν=2956,2915,2872,1461,1379,1154,1112,1047,921,740.
[0501] Example 8: Preparation of 4,6,8,10-tetramethyltridecanol (7)
[0502]
[0503] The 4,6,8,10-tetramethyltridecylmethoxymethyl ether (6:R 1 =H) (36.09 g, 0.10 mol, purity 87.02%), methanol (50.50 g, 1.58 mol), 20% hydrochloric acid (5.05 g; 0.028 mol hydrogen chloride) were placed in a reactor equipped with a distillation column, and the reaction mixture was heated to 60°C and stirred for 1 hour. After the stirring was completed, the internal temperature of the reactor was heated to 65 to 70°C to distill off a mixture of by-product dimethoxymethane and methanol from the distillation column. The reaction mixture was sampled during the reaction. After confirming that the conversion rate was 100%, water (30.30 g) was added to the reaction mixture, followed by phase separation. The water layer was removed to obtain an organic layer. The organic layer thus obtained was concentrated under reduced pressure, and the resulting concentrate was purified by silica gel column chromatography (hexane:ethyl acetate=20:1 to 9:1) to obtain 4,6,8,10-tetramethyltridecanol (7) (27.19 g, 0.10 mol, purity 97.52%) in a yield of 100%.
[0504] The following are the spectral data of 4,6,8,10-tetramethyltridecanol (7) prepared in this way.
[0505] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.76-0.90(16H,m),0.90-1.42(12H,m),1.42-1.66(6H,m),1.42-1.67(6H,m),3.62(2H,t,J=6.9Hz); 13 C-NMR (125MHz, CDCl3): δ=14.37,14.42,19.25,19.34,19.94,19.97,20.02,20.06,20.1 2,20.15,20.31,20.35,20.44,20.50,20.64,20.95,27.21,27.24,27.27,27.30,27.39,2 9.67,29.72,29.76,29.83,29.88,29.98,30.19,30.21,30.37,32.55,32.86,34.11,38.80,39.44,40.56,44.25,44.31,45.08,45.37,45.66,45.89,46.11,46.22,63.43,63.47.
[0506] Mass spectrum: EI-mass spectrum (70eV): m / z 255 (M+ -1),238,224,210,195,181,167,153,139,125,111,97,83,69,43,29.
[0507] Infrared absorption spectrum: (D-ATR): νmax = 3325, 2857, 2914, 2871, 1460, 1378, 1058, 739.
[0508] Example 9: Preparation of 1-chloro-4,6,8,10-tetramethyltridecane (8:X 3 =Cl)
[0509]
[0510] 4,6,8,10-Tetramethyltridecanol (7) (21.89 g, 0.083 mol, purity 97.52%) obtained in Example 8, pyridine (9.88 g, 0.12 mol) and GBL (12.48 g) were placed in a reactor and stirred at 40° C. for 16 minutes.
[0511] Then methanesulfonyl chloride (CH3SO2Cl) (11.44g, 0.10mol) was added dropwise at 40 to 60°C. After the addition was completed, the reaction mixture was heated to 60 to 65°C and stirred for 10 hours. After the stirring was completed, water (20.81g) and hexane (12.49g) were added to the reaction mixture, followed by phase separation. The water layer was removed to obtain an organic layer. The organic layer thus obtained was washed with an acetic acid aqueous solution (prepared by acetic acid (0.89g) and water (10.95g)), and then washed with a sodium bicarbonate aqueous solution (prepared by sodium bicarbonate (0.44g) and water (10.95g). The organic layer thus obtained was concentrated under reduced pressure, and the concentrate obtained was purified by silica gel column chromatography (hexane: ethyl acetate = 20: 1 to 9: 1) to obtain 1-chloro-4,6,8,10-tetramethyltridecane (8: X 3 =Cl) (21.26 g, 0.076 mol, purity 98.37%), the yield was 91.40%.
[0512] The following is the preparation of 1-chloro-4,6,8,10-tetramethyltridecane (8:X 3 =Cl).
[0513] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.77-0.90(16H,m),0.90-1.65(15H,m),1.65-1.86(2H,m),3.52(2H,t,J=6.9Hz); 13C-NMR (125MHz, CDCl3): δ = 14.38, 14.44, 19.26, 19.36, 19.93, 19.95, 19. 99,20.04,20.11,20.16,20.26,20.38,20.51,20.63,20.94,21.03,27.2 5,27.29,27.31,27.32,27.41,29.45,29.51,29.55,29.62,29.75,30.14 ,30.18,33.61,33.79,34.09,38.82,44.34,44.95,45.24,45.51,45.66.
[0514] Mass spectrum: EI-mass spectrum (70eV): m / z 274 (M + ),259,245,231,217,203,189,175,155,133,113,99,85,71,57,43,29.
[0515] Infrared absorption spectrum: (D-ATR): νmax = 2957, 2914, 2871, 2844, 1461, 1379, 1158, 970, 726, 656.
[0516] Example 10: Preparation of 4,6,8,10,16-pentamethyldocosane (11)
[0517]
[0518] Magnesium (1.94 g, 0.080 gram atom) and tetrahydrofuran (70.16 g) were placed in a reactor at room temperature and stirred at 60 to 65° C. for 31 minutes. Then, 1-chloro-4,6,8,10-tetramethyltridecane (8:X 3 =Cl) (21.26 g, 0.076 mol, purity 98.37%) was added dropwise to the reactor at 60 to 75°C. After the addition was completed, the reaction mixture was stirred at 75 to 80°C for 5 hours to obtain 4,6,8,10-tetramethyltridecylmagnesium chloride (9:M 2 =MgCl).
[0519] Then, cuprous chloride (0.085 g, 0.00086 mol), triethyl phosphite (0.85 g, 0.0014 mol), lithium chloride (0.059 g, 0.0014 mol), tetrahydrofuran (132.71 g) and 1-bromo-3-methylnonane (10:X 4=Br) (16.32 g, 0.072 mol, purity 97.97%) was placed in another reactor, and then the prepared 4,6,8,10-tetramethyltridecylmagnesium chloride (9:M 2 =MgCl). After the dropwise addition was completed, the reaction mixture was stirred at 20 to 30°C for 2 hours. Then, an acetic acid aqueous solution (prepared from acetic acid (0.77 g) and water (20.97 g)), 20% by mass hydrochloric acid (1.59 g; 0.0087 mol hydrogen chloride) and a 25% by mass sodium hydroxide aqueous solution (1.59 g; 0.0099 mol sodium hydroxide) were added to the reaction mixture, followed by phase separation. The organic layer thus obtained was distilled under reduced pressure to distill off low-boiling impurities. The resulting concentrate was then purified by silica gel column chromatography (hexane = 100) to obtain 4,6,8,10,16-pentamethyldocosane (11) (24.29 g, 0.062 mol, purity 96.43%) in a yield of 80.86%.
[0520] The following are the spectral data of 4,6,8,10,16-pentamethyldocosane (11) prepared in this way.
[0521] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ=0.78-0.92(22H,m),0.92-1.18(8H,m),1.18-1.40(22H,m),1.40-1.63(4H,m); 13 C-NMR (125MHz, CDCl3): δ=14.14,14.40,14.45,19.33,19.39,19.45,19.73,19.97,20.01,20.05,20.08,20.18,20.21,2 0.45,22.72,27.08,27.14,27.26,27.28,27.31,27.35,29.73,29.76,30.37,30.40,31.99,32.77,37.12,45.50,46.21.
[0522] Mass spectrum: EI-mass spectrum (70eV): m / z 380 (M + ),337,295,253,197,155,113,71,41.
[0523] Infrared absorption spectrum: (D-ATR): ν=2857,2925,2871,2854,1463,1378,1157,970,724.
[0524] Example 11: Preparation of 8-bromo-4,6-dimethylnonylmethoxymethyl ether (1': n+1=3, R 1 =H,X 1 =Br)
[0525]
[0526] Triphenylphosphine (PPh3) (5.51 g, 0.021 mol) and acetonitrile (CH3CN) (15.45 g) were placed in a reactor at room temperature and stirred at 0 to 10°C for 40 minutes. Bromine (BR2) (3.21 g, 0.020 mol) was then added dropwise to the reactor at 0 to 10°C. After the addition was complete, the reaction mixture was stirred at 0 to 10°C for 3 hours. Then, 8-hydroxy-4,6-dimethylnonylmethoxymethyl ether (4:n+1=3, R 1 =H) (3.69 g, 0.015 mol, purity 95.28%) and triethylamine (2.14 g, 0.021 mol) mixed solution. After the dropwise addition was completed, the reaction mixture was stirred at 15 to 25 ° C for 20 hours. Water (20.00 g) and hexane (6.60 g) were then added to the reaction mixture, followed by phase separation. The organic layer thus obtained was concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography (hexane: ethyl acetate = 50: 1 to 9: 1) to obtain 8-bromo-4,6-dimethylnonylmethoxymethyl ether (1': n+1 = 3, R 1 =H,X 1 =Br) (3.38 g, 0.0095 mol, purity 82.67%), the yield was 62.62%.
[0527] The following is the preparation of 8-bromo-4,6-dimethylnonyl methoxymethyl ether (1': n+1=3, R 1 =H,X 1 =Br).
[0528] NMR Spectrum: 1 H-NMR (500MHz, CDCl3): δ = 0.82-0.90 (6H, m), 0.90-1.45 (4H, m), 1.45-1.90 (9H, m),3.35(3H,s),3.50(2H,dt,J=1.9Hz,6.7Hz),4.14-4.25(1H,m),4.61(2H,s); 13C-NMR (125MHz, CDCl3): δ=18.56,19.14,19.42,19.45,19.51,19.81,20.29,2 6.21,26.50,27.09,27.15,27.19,27.29,27.31,28.81,28.87,28.89,29.66,2 9.75,29.79,29.84,32.64,33.39,33.94,34.44,43.52,44.25,44.72,45.08,48.09,49.04,49.18,49.54,49.57,49.63,60.25,50.40,55.09,68.16,96.37.
[0529] Mass spectrum: EI-mass spectrum (70eV): m / z 293 (M + -1),249,206,151,111,69,45.
[0530] Infrared absorption spectrum: (D-ATR): ν=2953,2925,2872,1457,1380,1214,1152,1111,1045,966,920,625,540.
Claims
1. A method for preparing a halogenated alkyl alkoxymethyl ether compound of the following general formula (1'): Where X 1 Represents a halogen atom, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group, and n represents an integer of 2 to 7, The method comprises the following steps: The following haloalkyl alkoxymethyl ether compound of general formula (1): Where X 1 , R 1 and n is defined as above, Converted into a nucleophile (2n+2)-alkoxymethoxyalkyl compound of the following general formula (2): Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 Represents a halogen atom or Z 2 , and Z 2 express, Where R 1 and n are as defined above, and the wavy line indicates an abbreviated epitaxial structure; The nucleophile (2n+2)-alkoxymethoxyalkyl compound (2) is then subjected to a nucleophilic addition reaction with propylene oxide of the following formula (3): To obtain the following hydroxyalkyl alkoxymethyl ether compound of general formula (4): Where R 1 and n is as defined above; And subjecting the hydroxyalkylalkoxymethyl ether compound (4) to a halogenation reaction to obtain the above-mentioned halogenated alkylalkoxymethyl ether compound (1').
2. The method for preparing a haloalkyl alkoxymethyl ether compound (1') according to claim 1, wherein n in the haloalkyl alkoxymethyl ether compounds (1) and (1') represents 2, so that the haloalkyl alkoxymethyl ether compound (1') is a haloalkyl alkoxymethyl ether compound (1': n+1=3).
3. A method for preparing 4,6,8,10,16-pentamethyldocosane of the following general formula (11): The method The following steps are involved: The method for preparing the halogenated alkyl alkoxymethyl ether compound (1':n+1=3) according to claim 2; The halogenated alkyl alkoxymethyl ether compound (1': n+1 = 3) is converted into a nucleophilic reagent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound of the following general formula (2: n = 3): Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or an 8-alkoxymethoxy-1,3,5-trimethyloctyl group, and R 1 As defined above; Then, a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) is subjected to a coupling reaction with a 1-halogeno-2-methylpentane compound of the following general formula (5): Where X 2 represents a halogen atom, To obtain the following 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound of general formula (6): Where R 1 As defined above; The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) is subjected to a dealkoxymethylation reaction to obtain 4,6,8,10-tetramethyltridecyl alcohol of the following general formula (7): 4,6,8,10-tetramethyltridecanol (7) is subjected to a halogenation reaction to obtain a 1-halogeno-4,6,8,10-tetramethyltridecanol compound of the following general formula (8): Where X 3 represents a halogen atom; The 1-halogenated 4,6,8,10-tetramethyltridecane compound (8) is converted into a nucleophile 4,6,8,10-tetramethyltridecane compound of the following general formula (9): Among them, M 2 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or a 4,6,8,10-tetramethyltridecyl group; And then the nucleophile 4,6,8,10-tetramethyltridecyl compound (9) is coupled with the 1-halogeno-3-methylnonane compound of the following general formula (10): Where X 4 represents a halogen atom, To form the above-mentioned 4,6,8,10,16-pentamethyldocosane (11).
4. A method for preparing 4,6,8,10,16-pentamethyldocosane of the following general formula (11): The method comprises the following steps: The following halogenated alkyl alkoxymethyl ether compound of the general formula (1: n = 3): Where X 1 represents a halogen atom, and R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group, Converted into a nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound of the following general formula (2: n = 3): Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or an 8-alkoxymethoxy-1,3,5-trimethyloctyl group, and R 1 As defined above; Then, a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) is subjected to a coupling reaction with a 1-halogeno-2-methylpentane compound of the following general formula (5): Where X 2 represents a halogen atom, To obtain the following 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound of general formula (6): Where R 1 As defined above; The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) is subjected to a dealkoxymethylation reaction to obtain 4,6,8,10-tetramethyltridecyl alcohol of the following general formula (7): The 4,6,8,10-tetramethyltridecanol (7) is subjected to a halogenation reaction to obtain a 1-halogenated-4,6,8,10-tetramethyltridecanol compound of the following general formula (8): Where X 3 represents a halogen atom; The above 1-halogenated-4,6,8,10-tetramethyltridecane compound (8) is converted into a nucleophilic reagent 4,6,8,10-tetramethyltridecane compound of the following general formula (9): Among them, M 2 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , and Z 1 represents a halogen atom or a 4,6,8,10-tetramethyltridecyl group; And then the nucleophile 4,6,8,10-tetramethyltridecyl compound (9) is coupled with the 1-halogeno-3-methylnonane compound of the following general formula (10): Where X 4 represents a halogen atom, To form the above-mentioned 4,6,8,10,16-pentamethyldocosane (11).
5. A method for preparing 4,6,8,10,16-pentamethyldocosane of the following general formula (11): The method comprises the following steps: The following haloalkyl alkoxymethyl ether compound of general formula (1') Where X 1 Represents a halogen atom, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group, and n represents 2, Converted into a nucleophile 8-alkoxymethoxy-1,3,5-trimethyloctyl compound of the following general formula (2: n = 3): Among them, M 1 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or an 8-alkoxymethoxy-1,3,5-trimethyloctyl group, and R 1 As defined above; Then, a nucleophilic agent 8-alkoxymethoxy-1,3,5-trimethyloctyl compound (2: n=3) is subjected to a coupling reaction with a 1-halogeno-2-methylpentane compound of the following general formula (5): Where X 2 represents a halogen atom, To obtain the following 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound of general formula (6): Where R 1 As defined above; The 4,6,8,10-tetramethyltridecyl alkoxymethyl ether compound (6) is subjected to a dealkoxymethylation reaction to obtain 4,6,8,10-tetramethyltridecyl alcohol of the following general formula (7): 4,6,8,10-tetramethyltridecanol (7) is subjected to a halogenation reaction to obtain a 1-halogeno-4,6,8,10-tetramethyltridecanol compound of the following general formula (8): Where X 3 represents a halogen atom; The above 1-halogenated-4,6,8,10-tetramethyltridecane compound (8) is converted into a nucleophilic reagent 4,6,8,10-tetramethyltridecane compound of the following general formula (9): Among them, M 2 Indicates Li, MgZ 1 ,CuZ 1 or CuLiZ 1 , Z 1 represents a halogen atom or a 4,6,8,10-tetramethyltridecyl group; And then the nucleophile 4,6,8,10-tetramethyltridecyl compound (9) is coupled with the 1-halogeno-3-methylnonane compound of the following general formula (10): Where X 4 represents a halogen atom, To form the above-mentioned 4,6,8,10,16-pentamethyldocosane (11).
6. A halogenated alkyl alkoxymethyl ether compound of the following general formula (1'): Where X 1 Represents a halogen atom, R 1 represents a hydrogen atom, an n-alkyl group having 1 to 9 carbon atoms, or a phenyl group, and n represents an integer of 2 to 7.
